Metabolism of drugs in isolated hepatocytes and proliferating liver tissue by Henderson, P.T.
metabolism of drugs 
in 
isolated hepatocytes 
and 
proliferating liver tissue 
p. th. Henderson 

METABOLISM OF DRUGS IN 
ISOLATED HEPATOCYTES AND 
PROLIFERATING LIVER TISSUE 
PROMOTORES : 
PROF. DR. E.J. ARIENS 
EN 
PROF. DR. CH.M.A. KUYPER 
METABOLISM OF DRUGS IN 
ISOLATED HEPATOCYTES AND 
PROLIFERATING LIVER TISSUE 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN DOCTOR 
IN DE WISKUNDE EN NATUURWETENSCHAPPEN AAN DE 
KATHOLIEKE UNIVERSITEIT TE NIJMEGEN, OP GEZAG VAN 
DE RECTOR MAGNIFICUS DR. G. BRENNINKMEIJER, 
HOOGLERAAR IN DE FACULTEIT DER SOCIALE WETENSCHAPPEN, 
VOLGENS BESLUIT VAN DE SENAAT IN НБГГ OPENBAAR 
TE VERDEDIGEN OP DONDERDAG 17 JUNI 1971, 
DES NAMIDDAGS TE VIER UUR 
DOOR 
PETRUS THOMAS HENDERSON 
GEBOREN TE TEGELEN 
NIJMEGEN, 1971 
It is a pleasure here to thank all those who, 
in various ways, have helped me in the present work. 
C O N T E N T S 
INTRODUCTION VII 
I. SOME METHODS FOR THE IN VITRO STUDY OF DRUG METABOLISM 
1. Hepatic N-demethylation of aminopyrine in rat and 
trout.
 B i o c h e m . Pharmacol., Vol.17 (1968) pp. 1901-1907 
2. Activation in vitro of rat hepatic UDPglucuronyl-
transferase by ultrasound. 
Life Sciences, Part II, Vol.9 (1970) pp. 511-518 
II. APPROACHES TO THE STUDY OF DRUG MKTABOLISM IN ISOLATED 
LIVER CELLS 
1. Metabolism of drugs in isolated rat hepatocytes. 
Biochem. Pharmacol., Vol.18 (1968) pp. 2087-2094 
2. Phénobarbital induction of UDPglucuronyltransfer-
ase in isolated rat hepatocytes. 
Life Sciences, Part II, Vol.10 (1971) in press, pp.1-6 
III.STUDIES OF DRUG METABOLISM IN PROLIFERATING LIVER TISSUE 
1. Metabolism of drugs during rat liver regeneration. 
Biochem. Pharmacol., Vol.19 (1970) pp. 2343-2351 
2. Metabolism of drugs in rat liver during the peri-
natal period. 
Biochem. Pharmacol., Vol.20 (1971) in press, pp. 1-8 
SUMMARY XII 
SAMENVATTING XIV 

I N T R O D U C T I O N 
The interactions between pharmaca and living organisms may 
be considered to be mutual. On the one side, pharmaca inter-
fere with the organism through an alteration of functional 
processes, whereas on the other side, the organism will be 
able to bring about a metabolic modification in the pharmacon 
molecule thereby influencing its distribution and excretion. 
This may have consequences for the concentration of the drug 
in the various compartments, and therewith for the intensity 
and duration of action. 
The main site of the metabolic conversion of drugs is the 
liver, although other tissues can also participate. In this 
respect, the liver takes a strategic position, especially as 
far as orally administered pharmaca are concerned, since com-
pounds absorbed from the stomach and intestine into the blood 
stream directly enter the hepatic portal circulation.Studies 
with subcellular fractions from the liver have revealed that 
most of the enzyme systems which catalyze the alteration of 
drugs are present in the endoplasmic reticulum. In order to 
reach these hepatic enzymes, lipid cell barriers have to be 
crossed, and therefore, a certain degree of lipid-solubility 
is necessary for the compounds which serve as substrates in 
these reactions. 
In the biotransformation of drugs two main processes,most-
ly occurring in sequence, can be distinguished: a nonsynthe-
tic change of the molecule (phase I), and a synthetic combi-
nation of the drug molecule with a bodily metabolite (phase II) 
(Figure 1). Phase I includes those reactions which can be cat-
egorized into three types of chemical alteration: oxidation, 
reduction and hydrolysis. In these reactions polar groups are 
introduced into the molecules, making them accessible to phase 
II reactions, e.g. conjugation with glucuronic acid. The con-
jugation products are hydrophilic and are transported actively 
from the liver cell into the blood or bile fluid. 
As a consequence of the changes in the body-foreign molecule 
(introduction or removal of reactive groups) induced in the 
phase I reactions, it may happen that biologically active 
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compounds are inactivaxed or have their activity changed, and 
that inactive compounds are activated. Second phase reactions 
(conjugations) as a rule appear to be inactivating processes. 
It is a characteristic feature of hepatic drug metabolism that 
drugs are changed from lipophilic to more hydrophilic substan­
ces. This has important consequences for the distribution of 
the substance in the body, and greatly facilitates renal and 
biliary excretion of pharmaca, due to zhe negligible reabsorp­
tion of the hydrophilic products. 
The biochemical conversion of a drug in the liver thus 
plays a role in modifying the pharmacological effect in the 
organism. In general, the term detoxication may be utilized 
to define this process. 
Studies during the past decade have shown that the applic­
ation of certain foreign compounds, including drugs, insecti­
cides, herbicides, and carcinogenic hydrocarbons, lead to a 
stimulation of their own metabolism and the metabolism of 
other pharmaca. This stimulation is mostly referable to enzyme 
induction, since the concentration of enzyme protein is 
increased. Conney (1967) reviewed the characteristics of a 
great number of inducing agents. 
IX 
For a detailed description of the different types of reac-
tions involved in the biotransformation of pharmaca, and the 
various factors affecting the enzymatic activities, the exten-
sive reviews of Williams (1959), Gillette (1963; 1966), Ariëns 
and Simonis (1964), and Gillette et al. (1969) may be of 
reference. 
The work described in this thesis was initiated by the 
question of whether or not, it would be possible to establish 
a continuous culture of hepatic cells - possibly of human 
origin - suitable for the study of the metabolism of drugs. 
In such an in vitro system of liver cells it should be of 
prime importance that liver function is preserved, at leas<,as 
far as the biotransformation of drugs is concerned. Though 
this ultimate aim seems somewhat Utopian, an orientating study 
would be a major contribution, since the realization thereof 
would mean a considerable extension of the field of human 
pharmacology. 
In the normal in vivo condition the liver is an organ con-
sisting of differentiated cells, exhibiting little, or no, 
proliferation. On the other hand, liver cell cultures as a 
rule consist of rapidly proliferating cells. It is a common 
experience that specialized animal cells incline to dediffer-
entiation during rapid proliferation in vitro, which implies 
that liver cells in a continuous culture will show little of 
their specific hepatic functions. This in fact would pose a 
dilemma with regard to the use of growing cell cultures for 
the study of drug metabolism. 
The studies presented in this thesis concentrate on: 
- An analysis of some methods used in the in vitro study of 
hepatic drug metabolism; 
- An investigation of certain drug-metabolizing capacities 
of isolated hepatocytes; 
- An investigation of the relationship between cellular pro-
liferation and the in vitro capacity of liver to metabol-
ize pharmaca. 
These topics are elucidated below. 
I. SOME METHODS FOR THE IN VITRO STUDY OF DRUG METABOLISM 
In the present research, typical examples of drug-metabol-
izing reactions, viz. the oxidative N-demethylationof amino-
pyrine, p-hydroxylation of aniline, and the glucuronidation 
of p-nitrophenol were studied in vitro. The first study (1.1.) 
of this chapter was undertaken to develop a suitable method 
for the in vitro assay of the N-demethylation of aminopyrine. 
The second paper (1.2.) also deals with the search for a suit-
χ 
able technique, namely for the measurement of the in vitro 
activity of UDPglucuronyltransferase. 
II. APPROACHES TO THE STUDY OF DRUG METTABOLISM IN ISOLATED 
LIVER CELLS 
Information was gathered about the drug-metabolizing cap­
acity of hepatic cells detached from the organized tissue. Such 
isolated hepatocytes offer many advantages, in that they afford 
the possibility of studying drug metabolism in the absence of 
the complex variables of humoral, neural, and other origin, 
which normally manifest themselves in the whole organism. 
Studies of drug metabolism with the aid of intact isolated 
hepatocytes may fill the gap between the in vitro experiments 
carried out with homogenates, microsomal and submicrosomal 
fractions of the liver, and the experiments on total organisms 
and perfused livers. 
The third paper (II.1.) of this thesis describes the prep­
aration of isolated hepatocytes from rat liver. Some charac­
teristics of the isolated cells with respect to the metabolism 
of drugs were studied, and compared to those of other liver 
preparations. In the next publication (II.2.) it is shown 
that isolated rat hepatocytes are suited for the study of drug 
metabolism at the cellular level. An induction of higher act­
ivities of UDPglucuronyltransferase was observed in isolated 
hepatocytes after phénobarbital treatment in vitro. 
III. STUDIES OF DRUG METABOLISM IN PROLIFERATING LIVER TISSUE 
Preliminary experiments on an established culture of liver 
cells, originated from calf liver ( Pieck and Kuyper, 1961), 
revealed that these rapidly proliferating cells are inactive 
in drug metabolism. This prompted us to study drug-metabol-
izing activities of liver tissue during proliferation, which 
is expected to be accompanied by a low degree of different-
iation. Firstly, the question was studied whether there is 
any relationship between rapid cellular proliferation and the 
alteration in drug-metabolizing activities in preparations 
from regenerating rat liver (III.l.) Finally, some efforts 
are described ( III.2.) to correlate the observed changes in 
drug-metabolizing activities during the postnatal development 
with the rate of liver growth, histological changes in the 
liver, and the sexual differentiation of the rat. 
The results obtained are discussed in a general summary. 
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Abstract - Optimal conditions ha\ e been investigated for the in vitro assay of the hepatic 
,V-deinclh>latum of aminopyrme in rat (Wistar) and trout (Salmo ¡rideus). In rat and 
tmut A'-demeth>lase shows differences in optimum temperature, stability and substrate 
affinity The pll optimum is identical. Adverse actions of nicotinamide and semi-
carbazidc, commonly Ubcd in the test, are discussed. 
It is .shoun that under standardized (optimal) conditions per unit of liver weight the 
activity of the rat is about 15 times that of the trout. The significance of this difference 
is discussed 
A GROUP of enzymes dissimilating various compounds of exogenous origin, especially 
drugs, has been studied extensively during last years in mammalian livers. Up to a 
short time ago it was suggested1 • '- that, contrary to terrestrial animals, aquatic animals 
(fishes, tadpoles of frogs and toads, and certain frogs) were not provided with oxidative 
capacity or the possibility of conjugation of various drugs, because of the lipoidal 
character of gills and/or skin through which excretion of lipid-soluble compounds 
could take place. Recently, however, evidence began to rise that also in the livers of 
some aquatic animals an although very slight capacity for drug metabolism is 
present.3^11 Considering the in litro assays for many drug-metabolizing enzyme 
activities the lack in uniformity in the methods reported by the various investigators 
is striking.0· 7 ·8 ·1 8 · 2 ϋ · 2 1 · 2 2 For this reason conclusions about quantitative aspects 
of the concerning enzymatic activities can be hardly drawn. Especially difficulties will 
arise in a comparative study of drug metabolism in several species. Among the 
enzymatic systems concerning drug metabolism, which are localized in the microsomal 
fraction of liver homogenates, the oxidative Л'-dealkyIation has become recognized 
as a major pathway.12 In the present study an effort has been made to determine some 
optimal conditions for the HI vitro assay of the hepatic /V-dcmethylation of aminopyrine 
in rat and trout in order to obtain comparable enzymatic activities. 
MATERIALS AND METHODS 
The animals used were adult male rats (Wistar) about 3-4 months old, weighing 
200-300 g and rainbow trouts {Salmo iricíeus) about 1-5 yr old, weighing 150-180 g. 
The trout (bred by Kon. Ned. Heide Mij., Arnhem, The Netherlands) were kept in 
* Suppoited in part by grants from the Netherlands' Organization for the Advancement of Pure 
Research (Z.W.O.) 
The authors are indebted to Professor Dr E. J. Ariens for the valuable suggestions and advice in 
this study. 
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cooled aerated water. Both rat and trout were sacrificed by decapitation and 25 % 
liver homogenates were prepared at 2-4° with a Potter-Elvehjem homogenizer in 
0-25 M isotonic sucrose containing ΙΟ - 3 M sodium ethylenediamine tetraacetate 
(EDTA-Na) and 5 X IO - 2 M Tris(hydroxymethyl) aminomethane-HCl buffer 
(pH 7-4). The homogenates were centrifuged at 9000 g for 20 min at 2° and the 
supernatants were used for the enzyme assays. In experiments in which the cellular 
localization of the enzyme was studied the 9000 g supernatants were centrifuged at 
105000 g during 60 min at 2° with a Christ preparative ultracentrifuge (Omega II). 
Unless otherwise indicated the enzyme assay media contained 5 χ IO - 2 M tris-HCl 
(pH 8-0), 5 χ ΙΟ - 3 neutralized semicarbazide hydrochloride 8 χ Ю - 4 M MgCb, 
8 χ IO - 6 M МпСЬ, 5 χ IO - 3 M sodium isocitrate, 10 μg isocitric dehydrogenase 
per ml (Sigma type IV, capable of reducing 5-7 /umole NADP/min/mg) and saturating 
levels of aminopyrine and NADP. After preincubation of the assay media during 
10 min, the reaction was started by adding the 9000 g supernatants. The total 
volume of the reaction mixture was 3 ml, containing about 3Ό mg/ml liver protein. 
After incubation the reaction was stopped by the addition of 0-5 ml 25 % ZnSO^HzO 
and 0·5 ml saturated Ba(OH)2. After cooling the precipitated protein was removed by 
centrifugation at 18000 g for 10 min. The amount of formaldehyde in the super­
natant was determined according to the method of Nash,13 as modified by Cochin 
and Axelrod.14 The protein was determined according to the method of Lo wry et 
α/.15 
RESULTS 
Influence of temperature, incubation time and pH on the enzyme activity 
It has been demonstrated by some authors3- 4 ' 7 · 1 6 that the enzymes of poikilo-
therms and homoiotherms show differences in their optimum temperature. Since a 
temperature optimum is the resultant of two opposed factors—the rate of enzymatic 
conversion and the thermal denaturation of the enzyme—the optimum temperature 
measured depends on the length of the period during which the enzyme activity is 
determined. 
Fig. 1 illustrates the optimum temperature* for the enzymatic N-demethylation of 
aminopyrine by the 9000 g supernatants from liver homogenates of trout and rat 
estimated at pH 80. After an incubation time of 10 min a clear difference in optimum 
temperature for the enzymatic activities becomes manifest. After much longer 
incubation periods—for instance 60 min—this distinction is less striking in view of the 
fact that the denaturation of the enzymes has been further progressed. 
The decrease of the enzyme activities at different temperatures as a function of time 
is shown in Fig. 2. The decrease in enzyme activity of trout TV-demethylase at 25° is 
rather slow. The ЛГ-demethylation is found to be unchanged for 20-30 min and then 
declines. On the contrary, at 37° the drop in activity starts much earlier and is more 
pronounced. The N-demethylating enzyme of the rat, too, appears to be more stable 
at 25°, but the maximal activity at this temperature is only a fraction of the maximal 
activity at 37°. At 37° the rat JV-demethylase activity is found to be constant only for 
5-10 min, and then rapidly declines! Also from these results it appears that there is a 
clear-cut difference in optimum temperature at which the demethylating enzymes of 
the two species show their maximal activity, which lasts only for a relatively short 
period. 
I t has t o be s t r e s s e d L h u the a c t u a l v i l u e s of I he optinum tempera t u r e r e p o r t e d here have only prac t i c -
i s i g n i Γιcanee for the s t i h i L i t y o í the enzyme p r é p a r â t ion under the d e s c r i b ed t e s t < ondi 11 ons , 
Τ I a t e г хрег i n e n t s have r e v e l l e d l i n t t h e d e c r e a s e in a c t i v i t y i s rrainly due t o an ι n ie t f e re nee b\ NAD PH 
p r e s e n t i n the i n c u b i t i o n medlun . Only a p p r o x i m a t e l ) 10 per t e n t l o s s in a c t i v i t y * T S detcc ted in 900(1 g 
supe m i t a n t s from r a t l i \ e r a f t e r pre ine u b a t i on at 37 "-"C for 2 hr m t h o u t any addi t i o n s . 
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TEMPERATURE OPTIMUM N-DEMETHVLASE 
TROUT -
formaldehyde ( i imoles/g liver-h) 
RAT 
formaldehyde (^iinolee/g liver-h) 
temperature 
f-i<j. 1. Optimum temperatuies for the A'-demeth>lation of aminopyrine b> 9000 g ьирегпаіапіь 
derived from liver homogenates of trout and rat The enzyme activities are expressed as emoles 
formaldehyde produced hi 'g fresh liver. The optima were measured during different incubation 
periods: φ % trout, IO mm incubation, ' - - j trout, 60 mm incubation; % Щ rat, 
10 mm incubation;' - ' rat, 60 min incubation 
formaldehyde (^umoles/g liver -h) — —, 
N-demethylaae 
60 90 120 
incubat ion t i m e (min) 
Fio 2. The decrease ot the Л-demethylating enzyme activities in the 9000 ^ supernatants from livei 
homogenates of rat and trout at 37' and 25° as a function of time i-nzyme activities are expressed as 
/imoles formaldehyde prodiiccd;hr/g fresh liver 
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The 7V-demethylase activities of rat and trout have also been compared using test 
systems of different pH, obtained by preparing incubation mixtures with tris-HCl 
buffer solutions of different pH. The stated pH-values have been determined during 
incubation. Fig. 3 represents these enzyme activities assayed at optimum temperatures, 
after incubation times of 10 and 20 min for rat and trout respectively and in the 
presence of saturating levels of aminopyrine and NADPH. It can be remarked, that 
the pH-optima for rat and trout liver enzyme are equal and approximaely 8. 
pH-OPTIMUM N-DEMETHVLASE 
T R O U T - 1 
f o r m a l d e h y d e ( jumoles/g liver -h) 
2-5 
2-0-
1-5-
1-0-
6-0 7-0 6-0 9-0 
pH 
F I G . 3. Optimal pH for the N-demethylaiion of aminopyrine by 9000 g supematants derived from 
liver homogenates of trout and rat. Enzyme activities are expressed as pinoles formaldehyde 
produced/hr/gram fresh liver. % # rat; % φ trout. 
Influence of substrate concentration 
In the oxidative W-demethylation experiments in which aminopyrine was used as a 
substrate, for rat liver N-demethylase in 9000 g supernatant the K
m
 for aminopyrine is 
6-1 χ Ю - 4 M, assayed by 10 min incubation at 37°, pH 8-0. For trout liver N-
demethylase in 9000 g supernatant the Km for aminopyrine is 2-1 X IO - 3 M, assayed 
by 20 min incubation at 25°, pH 8-0. For measurements of maximal iV-demethylase 
activities both of rat and trout a saturating concentration of aminopyrine (16-7 χ 
ΙΟ
- 3
 M) was used. Higher levels of aminopyrine, f.i. 33-3 χ IO - 3 M, caused an 
inhibition of the enzyme activity. NADPH was supplied to the enzymatic system via 
generation from NADP by the isocitric dehydrogenase reaction. In order to ensure 
reduction of all NADP to NADPH the assay media were preincubated for 10 min 
prior to the addition of the 9000 g supernatants. The /r
m
-values for NADPH were 
assayed by adding increasing amounts of NADP in the presence of sufficiently high 
concentrations of isocitric dehydrogenase and isocitrate. For rat and trout N-
demethylase the A^m-values for NADPH are 4 0 <10-eMand2-2 χ ΙΟ"5 M respectively. 
In measurements of maximal JV-demethylase activities both of rat and trout the 
saturating concentration of NADP used was 8-8 X IO - 5 M. Besides aminopyrine and 
RAT 
formaldehyde (^imoles/gl iver-h) 
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NADPH also a good supply of molecular oxygen is necessary for maximal N-
demethylation. For this reason during the incubation the test media were saturated 
with air by shaking. 
influence of nicotinamide and semicarbazu/e 
Requirements of semicarbazide and nicotinamide in measuring /V-demethylase 
activities are reported by many investigators.18 2 2 Semicarbazide is mentioned to 
function as a trapping agent for the formaldehyde produced in the enzymatic reaction.22 
Nicotinamide is supposed to inhibit the breakdown of NADP by liver pyridine 
nucleotidase.20·23 Recently an inhibition by nicotinamide of the aminopyrine У -
demethylation has been reported,by Schenkman et al.24 We could confirm the decrease 
in TV-demethylase activity applying nicotinamide in concentrations of 5 to 50 ν 10 Ά 
M. The inhibition, however, appears to be not simply competitive as suggested by 
Schenkman et «A,24 but more complex, since we found not only the A'm-values for 
aminopyrine to be increased, but also the maximal rates of conversion (V
milx) to be 
lowered by increasing amounts of nicotinamide, which implies a combination of 
competitive and non-competitive inhibition. The У -demethylase activity measurements 
mentioned in this study were carried out under optimal conditions for temperature, 
pH, incubation time and with saturating substrate concentrations. As can be seen 
from Table 1, the inhibiting action of nicotinamide is more pronounced in the 
jV-demethylation by trout liver enzyme than by rat liver enzyme. However, if the 
N-demethylating activity is measured for the rat at 25" (10 min incubation time). 
the inhibition of the activity by nicotinamide is stronger than at 37°. For the trout at 
37° (20 min incubation time), the inhibition by nicotinamide is also less than at 25 . 
If longer incubation times at 37° are involved (120 min), however, it is found that for 
the rat as well as for the trout nicotinamide gives a slight protection against the loss of 
activity caused by the prolonged incubation. That there is indeed a protection and not 
a re-activation follows from the observation that if the nicotinamide was added at the 
end of the incubation, the loss in activity remains unchanged 
Semicarbazide applied in concentrations higher than 5 ΙΟ - 3 M also causes an 
inhibition (Table 1). However, in this case decrease in the amounts of formaldehyde 
TABLE 1. INFLUENCE OF NICOTINAMIDI AND SEMICARBAZIDE ON THE 
W-DEMETHYLATION OF AMINOPYRINE 
Per ceni determinated formaldehyde* 
Nicotinamide rat liver trout liver 
Concentration (ΙΟ - 3 M) (37°, 10 mm incubation) (25°, 20 min incubation) 
0 100 100 
5 94 65 
20 82 51 
50 69 42 
Semicarbazide 
Concentration (IO - 3 M) 
0 82 76 
5 100 100 
8 97 94 
20 62 63 
50 7 9 
* The amounts of produced formaldehyde are expressed as percentages of the 
maximal values 
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тсаьшсчі with ihc method of Nash" is found not to be due lo an inhibition ol 
enzymatic activity but to an interference of semicaibazidc with the colorimetrie 
determination 1 Im could be demonstrated by m ι Uro assays of standard formaldehyde 
concentrations in the presence ot ascending amounts of semicarbazide, which below 
5 10 3 M had no influence, but in concentrations of 20 lu 3 M and 50 10 ' 
M depiessed color development to 80 per cent and 12 per cent icspectivcly 
Comparison ol the actnities in rat and trout in er under optimal ionditiom 
The assay of the \-demethylase activities with aminopynnc as a substrate in 9000 ç 
supernatants Irom rat liver and trout liver under optimal conditions -i e at З?"1 
during 10 mm and at 25 during 20 mm respectively, both at pH 8 0, without nicotin­
amide and in the presence of only s > Ю Λ M semicarbazide gives as comparable 
values a production of 15 0 f 2 6 ^тоіе formaldehyde/hr g rat liver and I I 0 3 
/¿mole formaldehydcihr g trout liver 
It has to be noted that the above mentioned results hold loi 9000 # ^.upcrnatanls 
It is well-known trom previous studies on localization of enz>me activity, that the 
microsomes are the principal site for A'-demethylation of aminopvnne Apart from 
enzyme assays in the 9000 g supernatants, also 105000 g sediments and 105000 ц 
supernatants have been tested under the above-mentioned conditions The activities 
per g liver assayed in the 105000 g sediments (microsomal fractions) were only 90 
per cent of the actnities measured in the 9000 g supernatants The lower activities 
may be due to a loss in enzyme activity caused by the longer preparative procedure 
(or the 105000g sediment No activity could be detected m the 105000 <r supernatants 
Considering the advantage of a rapid assay procedure all determinations have been 
done with 9000 ρ supernatants It can be remarked that, using 9000 i? supernatants 
both from rat and trout liver, the enzyme activities measured were directly pro­
portional to increasing amounts of enzyme extract applied to the test system, calculated 
as mg 9000g supernatant protein per ml reaction mixture, up to a protein concentration 
of 5 0 mg/ml 
D I S C U S S I O N 
In a suivey about drug metabolism in marine vertebrates Adamson17 emphasizes 
the difTcrences in the nature of enzymes in the various species In the present compara­
tive study the optimal in uiro conditions ol the /V'-demethylation of ammopyimc in 
the livers of rat and trout have been investigated In accordance lo previous 
results3·л 7 1 6 in this study, too, a dilferencc in temperature optimum 37 fortherat 
and 25 for the trout, is evident Moreover, il appears that in this respect the stability 
of the enzyme at different temperatures plays an important role The Л-demethylasc 
activity /н utro is constant only during a short period, especially if measured at 37 
The pH-optima are equal for rat and trout and arc approximateK 8 The A,„ 
values of aminopynnc and NADPH for the trout /V-demcthylase appear to be aboui 
4 limes higher than the values for the rat enzyme Concentrations ot scmicarba/ide 
higher than 5 10 * M in the reaction mixture have to be avoided because of their 
mteiference with the colorimetrie determination of formaldehyde 
The results described in this paper indicate that there is a clear Λ demethylasc 
activity in rainbow tiout liver This activity is about 500 limes higher than the 
activities tor this species measured by Buhlcr and Rasmusson25 and even higher than 
the activities in rat reported by these authors The only conversion ot substrale 
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shown in the rat under our specified conditions is a mono-.V-demethylation;36 this 
has been confirmed by us by TLC in both rat and trout. This may explain why 
Buhlcr and Rasmusson25 found little or no activity since they measured only the 
double У -demcthylated product, which is formed only after much longer incubation 
times. The rate of /V-demethylation of aminopyrine by the trout enzyme (Salmo ir ¡deus) 
as measured in atro under the conditions outlined, is about 15 times lower than that 
in the rat (Wistar) liver. Such a comparison is only reasonable if the measurements are 
carried out under optimal assay conditions. If one tries to draw conclusions from 
these in ritro activities about the rate of V-demethylalion of the drug//) vivo—which 
is hazardous -it can be stated that since in the trout studied the liver weight is 
only about 1 per cent of the total body weight and in the rat about 4 per cent, the /V-
demethylation capacity in the liver of the rat per unit of body weight is approximately 
60 times higher than for the trout. The question remains, whether- besides the possi-
bility that other mechanisms for disposition are present—the apparently low drug-
metabolizing capacity in fish will be nevertheless sufficient to dispose of compounds 
foreign to the body. Relating the difTerent levels of drug-metabolizing capacity in 
two totally different species, like the homoiolhermous rat and the poikilothermous fish 
to a basic parameter such as resting metabolism—which in its turn is related to the food 
intake and therewith to the degree of exposure to body-foreign compounds—might 
greatly reduce the difference in detoxificating capacity reported. 
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Introduction 
The in vitro activity of hepatic UDPglucuronyltransferase (UDPglucuro-
nate glucuronyltransferase, E.C. 2.4.1.17), which catalyzes the 
glucuronyl conjugation of a wide range of phenols, alcohols, amines, and 
fatty acids, can be modified by treatment with several agents, most of 
which are reported to give rise to a disintegration of the microsomal 
membrane structures (1, 2). An increase of the in vitro activity of 
UDPglucuronyltransferase in liver preparations after treatment with EDTA, 
sodium deoxycholate, Triton X-100, digitonin, has been demonstrated by 
Harminen (3), Van Roy et al. (4), Heirwegh et al. (5), and Winsnes (6). 
Recently it has been found, too, by Lueders et al. (7) and by Winsnes 
(6) that preincubation of mouse and rat liver suspensions in vitro at 
37 results in an enhanced activity of the microsomal UDPglucuronyltrans­
ferase. 
In the present communication the influence of ultrasound on the UDPgluc­
uronyltransferase activity in whole liver homogenates from rats is 
described. Further it has been investigated whether the enzyme kinetics 
at varying acceptor and UDPglucuronate concentrations are altered by 
ultrasonic treatment. 
Methods 
Adult male Wistar rats, about 3 months old, weighing 175 - 200 g, were 
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used. The aninuls were decapitated under liKht ether jnesthosi.i and 
il lowed to exs.inguinal e . The l i ver s were rapidly excised and cooled in 
crushed i c e . The t i s sue uds weighed, f inely minced, and pla<ed into 
1 volumes i t e - t o l d isotonic sucrose solut ion (0.25 M) containniK 
5 χ 10 M Tris(hydroxymethyl ) aminomethane HCl (pH 7.4) . 2(Γ, Homogen-
ates were then prepared with a Teflon-glass Pottei—Elvehjem type of 
homogeni7er. These homogenates were used in the assays for UDPglucuron-
yl t rans ferase a c t i v i t y . 
Ul t rasomcated homogenates were obtained by treatment of the home с-nates 
in a MSB 100 Watt Ultrasonic Dis integrator for 60 seconds (6 χ 10 
seconds with Interva l s of 1 minute) at maximum output, except where 
s lated otherwise. To avoid heating the tubes containing the homogenates 
were cooled with ice or a free7ing mixture during the u l t rasonic treatment. 
UDPglucuronyltransferase a c t i v i t y was determined using p-nitrophenol 
as acceptor s u b s t r a t e . The reaction mixture consisted of Tris-HCl 
buffer (pH 7.4) (5 χ 10~2 M), MgCl (J .3 χ 10~J M), saccharo-1 , 1-
lactone (3 χ 10 ' M), and, unless s ta ted otherwise, sa tura t ing levels of 
-3 
p-ni trophenol (1.4 χ 10 M), and uridine· ó'-diphosphoglucurona le 
(UDPglucuronale) (6 χ 10 M). The reaction »as s ta r ted bv adding l ivei 
homogenate, eciuivalent to 60 mg fresh weight, to a final volume ol 1.5 ml. 
The incubation was at J7 lor 10 or 20 minutes and the re u tion »as 
stopped with 1 ml e thanol . The mixture was deproleini7ed by centr i fug-
a t i o n . p-Nitrophenol has an absorption maxiirum at J98 nm, which d i s ­
appears on conjugation of the phenolic OH-group. Therefore the glucuronide 
production was measured i n d i r e c t l y by determining the dl sappe.iranc e of 
free p-ni trophenol. For t h i s purpose ali<|Uols ol the cleprolcini/od 
medium were added to 0.1 N VaOH and assayed spec trophol omet rie al ly at 
J9H nm. Blanks contained a l l reagents except UDI'gluc urona t e . In order to 
get a good quanti lie at ion of the en/ymatic ac t i v i t i e s , standard solut ions 
Vol. 9, No. 9 UDP-GLUCURONYLTRANSFERASE 513 
ni p-ni 11 o|jhcii<iL (onla in iUK he i t -de iuLun ' i l Ііоііні^ип.ііс- wi.'r<' * i i i u r l 
lliri>U|;li the· wluili' proi uiliiru. 
Itusul 1 s 
The me.in UDIVI m urnnyl 11 . u i s l e r isc a c l i v i l i u s .it s . i l u r i t i n n s u l i s t r a u - .imi 
с osubs t r ι te t one ent i'.il ions
 ( cxprussud as Rimólos p-ni Lr<jj)hc'nol < on jn^.i Li'd 
per hour per gr.ini l i v e r r Ιοί u n t r e a t e d homogenales and hijnio^ena l e s ul t r.i-
b o n n a t e d l o r bO seconds were l ' i . l ^ J . ' i and ΊΟ. И ¿_ 12 . Ί resi 'ei 1 ι vul у. 
I 
CO 40 60 00 seconds 
duration of ultrasonic treatment 
H O . 1 
The e i l e t I ol u l l r a s o n u o s c i l l a t i o n on IDPglucuronyl t r a n s l e r a s e 
a c t i v i t y ol r.it l i v e r homogenales . Kn/ymjlic a c t i v i t i e s a l t e r d i l f e r e n l 
l e n g t h of t r e a t m e n t a r e p r e s e n t e d r e l a t i v e t o t h e i r i n i t i a l v . i lues . 
I t i s shown i n i i R u r e 1 t h a t t h e a c t i v a t i o n depends on the d u r a t i o n ol the 
u l t r a s o n i c t r e a t m e n t . Мамігаі a c t i v i t i o n was reached a l t e r about »0 s e c o n d s . 
P r e i n c u b a t i o n for 10 min i n the p r e s e n c e of 0.0Vr T r i t o n \-100 did 
not r e s u l t i n a l u r t h e r i n c r e a s e of the en/ymatic a c t i v i t y in homogendtes, 
which were a l r e i d y n u \ i n , i l l y a c t i v a t e d by u l t r a s o u n d ; however, l o r 
P-NITR0PH5N0L 
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noii-sonii nled homoßennles ¡ι 'МНГг ι ne reise ol the UüPKlucvironyl tratis-
Іеімье activity was observed. A spontaneous increa.se of U D P R U K uron-
vllraiibfernse aclivity to a level of about ООСГ, was observed, il the 
liver homoReimlu was |)reintubated without additions at 37 for 1 hours 
which is in agreement with l,ueders et al. (7) and Winsnes (b). On the 
lonlr.iry, the en/vme activity ol homogenates previously activated by 
ultrasound only rose to about 125r( ol the initial values ufter incub-
o 
ation at :t7 for Ί hours. Consequently, ultrasound, 0.0Γ/Ό Triton \-l(H), 
о 
and ageing at H7 for 4 hours result in a threefold increase of the 
activity of the native liver homogenate. 
For the кгпеііс studies the conversion at varying substrate and cosub-
strate concentrations was measured after an incubation period of 10 ι,ιη. 
-1/V-104 
15 
1
 о untreated 
• ultrasomcated 10 
-4 
ι ι 1 I 1 
0 1 2 J 4 S-IC^M 
^p-mtrophenoll" 
1/V.104 
r 
2 3 4 S-IC^M 
[UDP-glucuronate]" 1 
FIG. 2 
The effect of ultrasonic· o s c i l l a t i o n on UDPglucuronyltransferase 
in r.it l i ver homogenates. Kinetic dota are plotted according to 
Lineweaver-Burk. 
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Saturation curves and Lineweaver-Burk plots (figure 2) of the kinetit 
data suggest that the Michaelis-Menten relationship exists under »he 
present assay conditions. A comparison of the apparent К -values oi 
p-mtrophenol and UDPglucuronate for UDPglucuronyltransferase in untreated 
and ultrasonnally treated liver homogenates is given in table 1. 
TABLE 1 
APPARENT MICHAELIS CONSTANTS (K ) OF p-NITR0PHE40L AND UDP-GLUCbRONAlE 
m 
FOR UDP-GLUCURO.VYI HiAiV^FERASE IN NATIVE AND ULTRASONICATFD I I 'Τ LIVER 
HOMOGENATES 
A p p a r e n t K
m
 (+ S . D . ) 
o f p - T i t r o p h e n o l (пъі) 
u n t r e a t e d 
homogen'» I e 
ultrasonicuted 
homogenatt 
0.28 + 0 . 0 1 
Аррагэпі iC
m
 (+ f-.IJ ) 
of UrPgnifuroi i t e (ml') 
u n t r e a t e d н« 
. , 0 .34 + O.OQ 
homogen i t e — 
ul t r a s o n i c a t e d 
homogenate 
η niimhor oj expcnme. i t s 
и s i g n i f i c a n t l y i i i l ' e r e n t , Г < 0.005 ( r t i U o x o n , two-sanple (c". l) 
як s i c n i m . int ly d i l i è r e n t , I < '1.005 (.ViUoxon, two-sample l e s t ) 
A s i g n i f i e .int i n c r e a s e of the appa ren t К -v. i lues due t o the u l t r a s o n i c 
v i b r a t i o n becomes n u i m l c s t , which may sugge i t lower a t l i n i l i e s l o r ai -
c u p t o r and UDPgluc uron i le i n s p i t e of a much h i g h e r V , the· m.iximum 
a c h i e v a b l e v e l o c i t y . 
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ü i s i u s b i o n 
At t e n i p l s t o s o l u l j i 1 ι / о UDI'i;! »с u r o n j 111 j n s f c ι ι·~ο b\ s o n n , us« 11 1 j t ι o n s 
» e r e o n l y p . u l l v e i i e c l i v e Ι ι ι Ι Ι ι υ ι Ί ο , s i n c e l i l i s p r o c e d u r e , a p p l i e d t o 
g u i n e a p i g l i v e r n n ι o s o m e s , r e s u l l e d i n a i o n s . i d e r a b l e l o s s o l о п / м -
i l i i K l i v i t y ( H , 9 ) . T h e o b s e r v a t i o n s p r e s e n t e d h e r e d e m o n s t r a t e t h a t 
u l I r . i s o n u i t i o n ol r a t l i v e r h o m o g e n a t e s r e s u l t s i n an o b v i o u s i m i e . i s e 
i n I D I ' g l u i u · >n\ 1 l i . i i i s l e r . i s e a i l i t i l \ , w h u h i s o l t h e saii'e u r d e ι o l 
πι i g n i l u d e a s t l t ι , i t s e ι b\ d e t e r g e n t s ч г p r e i т. uba t i o n a t J 7 . 
The p o s s i b i l i t y І.1"і1 t h e g r e a t e r p r o d u c t i o n o l p - m I r o p h e n y 1 g l u i u i i l­
l u d e a l l L i · u l t i · . i s o l i l i , m o n i s a t t r i b u t a b l e t o a l o w e r r a t e o l h y d r o l v s i s 
w i t h j - g l u t u r o m d a s e i s e x c l u d e d , b i n t u a l l e n / y m e a s ivs l a v e b e e n 
p e r l o r m e d i n t h e p r e s e n c e o l s ice h a r o - l , 4 - 1 ас t o n e , w h u h і ь a ki ον,η 
i n h i b i t o r o l / j - p l u c u r o n i d a s e ( 1 0 ) . 
K l l o r t s t o o b l a i n ( u r t h e r s t i m u l a t i o n o l u l t r a s o n i c i t e I h o m o g e n a l e s b\ 
i l e l e i g e n t s o r spur, I i n c o u s l y a t 17 a p p e a r e d I n be ι i i succ e s f u l . T h i s 
s u p p o i l s l io i d e a t l i i t a common p r i n c i p l e u n d e i l i e . s t h e s e i m r e a s e s o l 
e n / y m a l K a c t i v i t i e s . 
As r e p o r t e d p r e v i o u s l y ( 1 1 ) l o i i s o l a t e d r i t h e p a t o i v l e s a s t r i k m n 
i n c r e a s e o f l l l l ' g l i u ui o n v l 11 a n s l e r a s e a c t i v i t y li i s b e e n o b s e r v e d t o 
oc c u t a l t e r n i l ι a s o l i l e i l d i s r u p t i o n ol t h e c o l l s . I t v i s ч і р р о - o d t h e n , 
t h a t t h i s s t i m i l i m o n w ^ t h e l e s u l l of a d i s i η l e g r a t ' on ' μυ ^ s , ' j U · 
b a r , l e i s b c t A e e t i s u b s L i a t e o r l o s u b s . r a j ρ, ι I he» a c t i v e - . l i e - c i 'a· 
e t l / v n e . i l . i s i s i n г и ú r d a m e w i t h ( ' le i n , с il ι i Wi.isne1- ti ) Il ι m i h 
d e l e i g n i s ,i,ul pi e 11 с üb 111 с η e l u s e J i s p e r - , i o 4 n i e ni) -чи ι ι i l i ι ι i l imi 
i h o i j w i t h К І І Ч І І С · bs ' ι, s-^iiiB I h e ai l i v e s i ^ . s . I l h e b e e n ' ι μ ρ ' - ΐ ι ν ι 
In l l d n n i n e n e t a l . ( 1 ^ ) t h i t t ' • κ Ι ι ve s i t e n i l ' D P g l b ai . invi l r a n s l e i i s e 
i n l i v ^ r mie roso ine ^ i s s
v
ii ι o u n d e d bv a Ι ι ρ , η , i - i j i . , '\ suppt i sc 1 1 ι li 11 
ι p a r t l i l d l s n i p t i o n o I t ho 1 ι pi«1 b ι π ι, ι ! . ι ι • ι ι κ d ,c ' ι 11 m u 
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oj l ІН' en/yniu. Ilowrt'vor, <i s p i n i l n ((»'Ці ul.ilirm oí mu rosoinal phuspli/»-
li|>i<ls l>v |)li(»s|)h<)l ι pasu Λ or ( p iodutcs all ι nat Ι ι va 1 ι oil ol UDI'^ l ч< m ony 1-
Ι ι j n s l u r i so, wlm 11 < in be l u r l u H y resLorort by I he addi l i on oj |)hos|>lio-
l ip i t l m i i c l l i ' s (li)* This may sur l iest , th i t Ilio a( l i v i i y ol I ht on/yin«· 
<lc|>L-ii(ls on phosphol ip ids . 
Although i t w i l l liu hazardous in цепегаі lo draw Гаг-го ιι hi пц ι о т lus ions 
from ki net к. s t u d i e s peilormed with impure enzyme s\stenis, the present 
l e s u l t s obtained under the c o n d i t i o n s mentioned above, may provide 
ev idence that the appaient К
т
- і1иеь of prni Irophenol and IDI'glu« ut<jna le 
for UUl'tjlucuronyl trans ierabe are increased bv u l t r a s o i n c treatment oJ 
the l i v e r honogenales. 
In ьопіе prel iminary ex|Hiriments an u l t r i s o n с s t i m u l a t i o n )f UUPglut uron-
v l t r a n s f e r a s e has been observed, t o o , дП microsomal p r e p a n t i o n s J гот rüt 
l i v e r . Therefore the rapid mechanical treatment as descr ibed in t h i s 
paper seems to be ьиіt ble for an e f f e c t i v e s c l u b i l i / a t i o n of the enzyme 
and may be in some c a s e s preferable to chemical t reatments . 
nummary 
Homogcnates of r i t l i v o r were subjected to u l t r a s o n i c treatments. The 
UDPgluc uronyl t rans ferase a c t i v i t y of t reated and untreated honoftenales 
were determined using p-mtrophenol as acceptor . Ul Irasonic a l i o h causes 
a J—i fo ld i n c r e a s j of the apparent enrymatic a c t i v i t y . 
Kinet ic s t u d i e s at varying acceptor and UBPglucuronate с m'entra t io-)s 
demonstrate that u l t r a s o n i c treatment of the l i v e r homogenale r e s u l t s in 
a s i g m t i c a n t H K i e i s e of the apparent K
m
-values for UDPgl uc ui on\ 1 Ι ι a i s -
fer i s e . 
I t remains to be -n, whether the pre ent observación a l s o holds true 
for other types ul UDPglucuronvlt .ansferase . S tudios in th i s f i e l d are 
in progress . The rechanic il treatment described in t h i s t < mmuiucal ion ma ν 
be considered as a r ip id procelure for s o l u b i l i z a t i o n of LDPglucui onvl-
518 UDP-GLUeURONYLTRANSFERASE Vol. 9, No. 9 
transferase. 
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Abstract—Enzymatic activities for the iV-demelhylation of aminopyrine, thep-hydroxy-
lation of aniline and the UDP-glucuronidation of p-nitrophenol in isolated rat hepatic 
cells (intact and disrupted by ultrasonication) have been compared on the basis of DNA 
content to those in homogenates from fresh liver tissue and the crude microsomal frac­
tions prepaied from these homogenates. The influence of different preparative pioced-
ure.s on the enzymatic activities are discussed. The inhibitor of drug metabolism SKF 
525 A blocks the UDP-glucuronidation only in the intact isolated cells and not in the 
homogenates. in contrast, У -demethyIation is inhibited by SKF 525 A both in the 
intact cells and in the disrupted cells and in 9000 g supernatants from fresh liver homo­
genates This indicates that for the yV-demethylation a true enzyme inhibition is involved 
while for the UDP-glucuronidation a non-specific change in the properties of the mem­
branes leading to a reduced permeability for substrate or cosubstrate is more probable. 
The suspension of isolated hepatocytes appeared to be suitable to study various aspects 
of drug metabolism, especially their modifications due to changes in the cellular integrity 
and changes in the permeability of the membranes. 
IN RECENT years numerous investigations have been performed on biotransformation 
of drugs, with on the one side the whole animal as the subject and on the other the 
liver homogenate or microsomal cell fraction. Experiments on total animals and more 
recently on perfused livers have provided us with considerable information concerning 
the metabolic fate of many drugs, but, because of the complexity of the whole organ­
ism, it will be difficult to evaluate the experimental results with respect to the enzy­
matic reactions involved.1-4 Although a number of enzymatic mechanisms have been 
characterized by in vitro experiments carried out with more or less purified enzyme 
systems and subcellular fractions, these results cannot be correlated directly to the 
in vivo situation. In this respect a study of drug metabolism on the level of the intact 
but isolated hepatic cells may fill up the gap. Some attention has been paid to the study 
of drug metabolism in liver slices.5-7 We, however, prefer isolated liver cells to liver 
slices, since—it depends on the thickness of the slices—either the free diffusion of 
substrates and metabolites may be limiting and, moreover, a large fraction of the 
cells of the slices has been ruptured. The study described in this paper has to be 
regarded as an attempt to design a system of isolated liver cells, not subject to varia­
tions imposed in vivo by nerve, blood or hormonal supply, in which drug metabolizing 
capacities and the modification thereof can be investigated on the cellular level. The 
•The authors are indebted to professor Dr. E. J. Ariens, Institute of Phat macology, and to Professor 
Dr. Ch. M. A. Kuyper, Laboratory of Chemical Cytology, University of Nijmegen, for the valuable 
suggestions and advice in this study. 
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N-demethylation of aminopyrme, the hydroxylation of aniline and the glucuronida-
tion of p-nitrophenol have been compared in liver homogenates, crude microsomal 
fractions prepared in different ways and in isolated liver cells 
EXPERIMENTAL PROCEDURE 
Animals 
Male rats (Wistar) weighing about 180-220 g were used. 
Isolation of the hepatocytes 
Hepannized animals were given ether anesthesia and the livers were perfused in situ 
with about 60 ml of an ice-cold salme solution The perfused livers were rapidly 
excised, washed with the perfusion fluid and sliced into cubes of about 2 mmJ. After 
washing twice in succession with a calcium-free Tyrode solution the small liver pieces 
were incubated at 37° for 1 hr in a dissociating medium following Segard et al& 
consisting of inactivated bovine serum containing sodium citrate (3 >• 10-2M), sodium 
adenosine-5'-tnphosphate (10-3M) and MnCl¿(10_3M) During the dissociation 
process the liver suspension was agitated by magnetic stirring After incubation the 
suspension was filtered once through a Kleenex tissue to remove strands of connective 
tissue and non-dissociated pieces of liver tissue At this stage the suspension contained 
apart from the separated hepatocytes a number of cell fragments and erythrocytes 
The intact hepatocytes were separated by differential centrifugaron at low speeds 
The final cell sediment was resuspended in a known volume of ice-cold calcium-free 
Tyrode solution (Fig. 1). Cell counts were made on a hemocytometer(Burker-Turk) 
The yield varied from 10-30 χ IO6 cells per gram liver Enzyme activities were tested 
both m intact cells and cell homogenates. Homogenates from isolated cells were pre­
pared by treatment of the suspended hepatocytes in an ultrasonic desintegrator 
(MSE-100 Watt) 
Preparation of liver homogenates and crude microsomal fractions 
As far as enzymatic activities in fresh livers are concerned, these were measured in 
crude microsomal fractions prepared from liver homogenates Rats were killed by 
decapitation, the livers were rapidly excised and 20 % liver homogenates were prepared 
at 1-4° with a Potter-Elvehjem homogenizer in 0-25 M isotonic sucrose containing 
10~3 M sodium ethylenediamine tetraacetate (EDTA-Na) and 5 χ 10 ¿MTris(hydroxy-
methyl) aminomethane HCl buffer pH 7 4 
The homogenates were centnfuged at 9000 g for 20 mm at 2° and the supernatants 
were tested for enzymatic activities 
Respiration measurements 
Oxygen uptake by liver homogenates and isolated cells was measured manometn-
cally in a Warburg respirometer. The homogenates or the cells suspended in Tyrode 
solution (pH 7 4) were incubated for 30 mm at 37° with air as the gas phase in the 
presence of ATP (10~3 M) and sodium succinate (10~2 M) 
Enzymatic assays 
Ή-demethylation of aminopyrme. Optimal conditions for testing /V-demethylating 
activities in 9000 g supernatants from liver homogenates have been described earlier 
by Dewaide and Henderson.9 The assay media contained 5 χ ΙΟ"2 M Tris-HCl 
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(pH 80), 5 x 10-3 M semicarbazide, 8 χ IO"4 M MgCh, 8 χ IO"6 M MnCh, 
5 χ IO - 3 M sodium isocitrate, 10 mg isocitric dehydrogenase per ml (Sigma type 4, 
capable of reducing 5-7 Χ IO - 3 m-moles NADP per minute per mg) and 8-8 χ ΙΟ - 5 M 
NADP. In order to ensure reduction of all NADP to NADPH the assay media were 
preincubated for 10 min. 
Aminopyrine (16-7 X Ю - 3 M) was used as a substrate. The reaction was started by 
adding the 9000 g supernatant to this assay medium. The total volume of the reaction 
mixture was 3 ml. 
In the enzyme assays carried out with isolated cells the reaction was started by 
adding 3-5 χ IO6 cells suspended in a calcium-free Tyrode solution to the assay 
medium described before. In this incubation mixture thus obtained the isotonicity was 
provided by increasing the Tris-HCl buffer concentration to 6 X IO - 2 M, in order to 
ensure that the cells stayed intact during the incubation. This was controlled micro­
scopically at the end of the incubation period. 
After incubation at 37° the reaction was stopped by the addition of 0·5 ml 25% 
ZnS04 x 7H2O and 0-5 ml of a saturated Ba(OH)2 solution. 
After protein precipitation the amount of formaldehyde generated in the super­
natant was determined according to the method of Nash,10 as modified by Cochin and 
Axelrod.11 
Hydroxylation of aniline. The incubation mixture for the assay of hydroxylating 
activities had the same composition as the medium mentioned above in the JV-de-
methylation test, except for the substrate and coenzyme concentrations, which were for 
aniline 24 χ ΙΟ - 3 M and for NADP 13 χ ΙΟ - 5 M respectively. Semicarbazide was 
omitted. 
After incubation at 37° the reaction was stopped by the addition of 2 ml ethyl 
acetate. /7-Aminophenol was extracted by ethyl acetate and quantitatively determined 
following to the phenol indophenol method of Brodie and Axelrod.12 
Glucuronidation of p-nitrophenol. The glucuronidation was carried out with slight 
modifications following the method of Isselbacher.13 Homogenates and intact cells 
were incubated at 37° in a mixture containing Tris-HCl buffer (pH 7-4) (5 χ ΙΟ - 2 M), 
MgCla (3-3 χ IO"3 M), uridine-5'-diphosphoglucuronate (UDPGA) (3 χ IO"3 M), 
p-nitrophenol (7 χ IO - 4 M) and saccharo-l, 4-lactone (IO - 3 M). The total volume 
was 1·5 ml. The reaction was stopped by adding 1 ml ethanol. The glucuronide forma­
tion was measured indirectly by determining the disappearance of />-nitrophenol. For 
this purpose aliquots of the deproteinized medium were diluted with 0-1 N NaOH and 
assayed spectrophotometrically at 398 m/x. 
DNA assay. DNA was determined by the diphenylamine test following Burton14 
(1956) after a pre-extraction according to Wanka15 (1962). Calf thymus DNA (BDH) 
was employed as a reference standard in the calculation of the DNA content. The 
enzyme activities were expressed per ¿tg DNA. 
For all enzyme reactions standard solutions and blanks were carried through the 
whole procedure in order to get a good quantification of the enzymatic activities. 
RESULTS 
Viability of the isolated hepatocytes 
In order to ensure that the isolated liver cells suspended in calcium-free Tyrode 
solution are still viable, the rate of oxygen uptake was measured for the cells disrupted 
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by sonication, for the intact cells and for fresh liver homogenates. The respiratory 
capacities of the various preparations could be compared per/xg DNA (Table 1). It can 
be concluded that the respiratory capacity is maintained in our isolation procedure. 
N-demethylation ofaminopyrine. Figure 2a illustrates the У -demethylation activities 
of intact and sonicated cells as a function of the time. The enzymatic activity is found 
to be unchanged during the first 10-20 min of the incubation period and then decreases. 
The same pattern has been described for the A'-demethylation activity of the 9000 g 
supernatant from fresh liver homogenates (Dewaide and Henderson9). 
Table 2 represents the rates of jV-demethylation by isolated hepatocytes (before and 
after sonication), total liver homogenates and crude microsomal fractions, measured 
after 10 min incubation. 
TABLE 1. RESPIRATION MEASUREMENTS 
Mean oxygen uptake* per: 
gram liver 106 cells jtg DNA 
Homogenates 
from fresh liver 
Intact isolated cells 
Isolated cells 
after sonication 
108 
0 68 
0 76 
0 052 
0052 
0 058 
* average value expressed as μI Ог consumed per mm. 
я number of experiments. 
N-DEMETHYLATION OF 
A M I N O P V R I N E 
formaldehyde / 1 0 celle 
(ГТІД molee) 
HYDROXYLATION OF 
A N I L I N E 
p.aminophenol/10 cell· 
( τημ mole· ) 
CLUCURONIDATION OF 
p-NITROPHENOL 
p-mtrophenol/10 cells 
(m/i molee) 
300 
200-
100 
ι ι ι г 
20 4 0 6 0 
incubation time (mm) 
ι ι 
20 4 0 6 0 
incubation time (mm) 
^ г 
2 0 -40 
incubation time (mm) 
(a) 
(b) 
(c) 
FIG. 2. 
The W-demethylation of ammopnne by isolated rat hepatocytes. The enzyme activities are ex­
pressed as rriMmoles formaldehyde produced per IO6 cells during different incubation periods. 
The hydroxylalion of aniline by isolated hepatocytes. The enzyme activities are expressed as 
m/imoles p-ammophenol formed per 10е cells during different incubation periods. 
The glucuronidation of p-mtrophenol. Enzyme activity is expressed as mamóles p-nitrophenol 
conjugated per 10'' cells during different incubation periods. 
С О intact cells; С О sonicated cells. 
J f i^ ·* 
I id. I. Photomicrograph of ihe isolated rat Ьераіосуіеь m suspension. (Hematoxylin and cosin, > 360) 
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T A B L E 2. C O M P A R I S O N ОЬ SOMI D R U G - M F T A B O L I Z I N G AC ri\ ITIES IN D I F F E R E N T IN VITRO SYSTEMS FROM RAT LIVER 
Source of enzyme 
aclivity: 
.V-L)cmeth>lai.ion 
of ammopynnc 
mean activity* per. 
Hydroxylation 
of aniline 
mean activityt per: 
Glucuromdation 
of/)-nitroplienol 
mean activity^ per: 
gram 
liver 
10" 
cells 
mg 
DNA 
gram 
liver 
IO1' 
cells DNA 
gram 
liver 
10" 
cells 
mg 
DNA 
702 Ι·3Ι Total homogenates 
from fresh liver 
Crude microsomal frauions^ 15 00 2 21 
Intact isolated cells 
Isolated cells 
after ultrasomcation 
3 39 0 80 6 937 78 
^ 25 I 49 22 1280 104 
0 058 0 008 4 36 · 0 98 9 
0 044 0 008 3 32 - 0 85 5 
0 45 - 0 07 4 34 9 7 4 — 
0 62 0 20 14 26 7 6 5 
16-9 43 9 
I 50 0 80 0 11 r 0 05 8 
0 74 -0 21 0 06 h0-02 4 
12 9 - 3 6 6 
0 0 3 9 - 0 012 2 9 , 1 1 8 
- 0 393 . 0 069 29 6 - 7 5 7 
* Expressed as ^moles formaldehyde per hour 
t Expressed as mamóles p-aminophenol produced per hour 
I Expressed as /tmolcs p-nitrophenol conjugated per hour The UDP-glucuronyltransferase activities in the total homogenates and the crude microsomal 
fractions were assayed after ultrasonic treatment in contrast with the measurements of the Л'-demethylationand the hydroxylation, which were carried out 
with extracts prepared without ultrasomcation 
η The number of experiments 
§ 9000 g Supcrnatants prepared from fresh liver homogenates. For these fractions calculations of the activities per DNA have been based on the amount 
of DNA determined in the total homogenates before centrifugation at 9000 g. 
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Hydroxylation of aniline. From literature it is known that the enzyme system involved 
in the hydroxylation of aniline is more stable than the jV-demethylating system 
(Schenkman et al.16). In crude microsomal fractions the hydroxylating activity is 
stable for 1 hr. In the intact isolated hepatocytes, too, the activity is stable at least for 
1 hr; after disruption of the cells the activity declined after 45 min (Fig. 2b). In Table 2 
the rates of hydroxylation of aniline and iV-demethylation of aminopyrine are sum-
marized for various preparations. There is an appreciable loss in activity for the 
hydroxylation of aniline in the isolated liver cells. 
Glucuronidation of p-nitrophenol. The amounts of /»-nitrophenol conjugated by 
intact isolated cells and disrupted isolated cells for different incubation times are 
presented in Fig. 2c. There is a striking difference between the activities of intact and 
sonicated cells. This might be an indication that there is a permeability barrier for the 
substrate or the cosubstrate, which can be abolished by ultrasonic treatment. The same 
holds true for fresh liver homogenates and crude microsomal fractions. The mean 
UDP-glucuronyltransferase activities, expressed as m/umoles p-nitrophenol conjugated 
per hour per /ig DNA, were found to be 4-7 ± 1-6 and 3-8 ± 1-1 respectively. After 
sonication these activities increased to 16-9 + 4-3 and 12-9 ± 3-6 m/imoles per hour 
per /¿g DNA, the values represented in Table 2. Remarkably the reverse situation 
holds for the hydroxylation and ./V-demethylation reactions, where the activities of the 
various preparations decreased about 30 per cent after ultrasonication. 
The influence of SKF525 A. j9-Diethylaminoethyl diphenylpropylacetate (SKF 525 A) 
prolongs the activity of a number of drugs because of an inhibition of drug meta-
bolism in vivo.17·18 For a number of drugs also a block of the in vitro transformation 
by homogenates and microsomal fractions has been described.1 In the present study 
the influence of SKF 525 A (IO-4 M) on the N-demethylating and glucuronidating 
TABLE 3. INHIBITION BY SKF 525 A 
JV-demethylation of Glucuronidation of 
aminopyrine p-nitrophenol 
(per cent) (per cent) 
Total liver homogenates — 1 (3)* 
Crude microsomal fractions 36 (3) — 
Intact isolated hepatocytes 51 (3) 40(4) 
Disrupted isolated hepatocytes 40 (2) 5 (4) 
•The number of experiments is given in parentheses. 
capacities of the isolated hepatocytes has been investigated. SKF 525 A has been added 
to the isolated cells, the homogenates and the 9000 g supernatants just before the 
measurements of the enzymatic activities. This implies that in these experiments only 
the inhibitory action of the diphasic effect of SKF 525 A can be manifested.27 The 
results are summarized in Table 3, where the activity is expressed in per cent of the 
original activity. 
In those cases where the inhibition is the same in the various preparations, true 
enzyme inhibition is feasible. Large differences in the inhibition for the various pre-
parations possibly indicate an interference of SKF 525 A with the transport of sub-
strate or cosubstrate presumably by changes in the properties of the membranes 
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involved. The results obtained indicate that the inhibition of the jV-demethylation 
presumably is a true enzyme inhibition. The inhibition of the glucuromdation of 
p-mtrophenol for the intact isolated cells is strong as compared to the inhibition for 
the homogenates. This might be based on an effect of SKF 525 A at the level of the 
cell membrane such that the permeability for substrate or cosubstrate is reduced. 
Changes in the properties of the cell membrane under the influence of SKF 525 A 
could also be demonstrated by measuring the swelling of the isolated hepatocytes in 
a hypotonic medium, which is inhibited by SKF 525 A in a concentration of Ю - 4 M. 
The mean diameter of the isolated hepatocytes in an isotonic solution (0-9% NaCl) 
is 25-5 zt 1 -Ομ. After staying for 20 mm in a hypotonic solution (0-3 % NaCl) the mean 
diameter of these cells increases to 28-6 ± 0-4 μ; in the presence of SKF 525 A the 
mean diameter remained 25-5 ± 0-6 μ. This indicates that SKF 525 A causes a higher 
osmotic resistance. 
DISCLSSION 
The method described here for preparing a suspension of isolated hepatocytes 
yielded recognizable parenchymal cells, when the suspension was examined by light 
microscopy (Fig I). No damage to the morphological integrity of the isolated cells 
could be observed. Submicroscopical damage to the cell membrane cannot be ex­
cluded as a matter of fact. 
Comparison of the respiratory capacities of the isolated cells, intact or disrupted by 
somcation, with that of homogenized fresh liver tissue did not show essential differ­
ences. 
Comparing the drug-metabolizing activities on basis of DNA content it may be 
concluded that for the isolated cells the N-demethylating activity is about 100 per cent, 
the hydroxylating activity only about 25 per cent, and the glucuronidating activity 
about 50 per cent of that of the total homogenate. Ultrasonic disintegration of the 
total liver homogenate and crude microsomal fraction results in an about 30 per cent 
decrease of the /V-demethylating and hydroxylating activities, but in a remarkable, 
about 4-fold, increase in the glucuronidating activity. The same holds for ultrasoni-
cation of the isolated liver cells, where the glucuronidating activity even increases 
about 10-fold. The remarkable influence of ultrasonication on glucuromdation of p-
nitrophenol might be explained by the supposition, that beside the outer cell membrane 
also intracellular elements behave as substrate or cosubstrate barriers, the disorgani­
zation of which, for instance by ultrasonication, results m a stimulation of the activity. 
An increase of the microsomal UDP-glucuronyltransferase activity by treatment with 
digitomn has been demonstrated recently by Heirwegh et al.19 and by Hánninen.20 
No conclusive explanation can be given for the difference in the activities of UDP-
glucuronyltransferase in the sonicated cells and in the sonicated total homogenates 
prepared from fresh liver (Table 2). 
A number of divergent suggestions can be found in literature to explain the inhibi-
tory action of SKF 525 A on the metabolism of various drugs.21-23 Our results also 
suggest that SKF 525 A can act m various ways. The inhibition of the TV-demethyl-
ation of aminopynne being of the same order of magnitude for the various prepara-
tions presumably can be attributed to a true enzyme inhibition as observed previous-
ly 23,24 The blocking action of SKF 525 A on the glucuromdation of p-mtrophenol 
only takes place in the intact isolated cells (Table 3). The most likely explanation, 
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therefore, is a change on the level of the cell membrane resulting in, for instance, a 
reduced permeability for the substrate or cosubstrate. This may also explain the 
seemingly contrary findings of Cooper et al.,6 who reported an inhibition of the 
glucuronidation by SKF 525 A in rat liver slices, and of Goldstein et al.,25 who did 
not find any inhibitory effect of SKF 525 A on the o-aminophenol conjugation by liver 
homogenates. An influence on the cell membrane also becomes apparent from the 
experiments m which the osmotic resistance of the isolated hepatocytes is found to be 
increased by SKF 525 A. Similar results were recently reported for human erythrocytes 
by Lee et α/.26 (1968). 
The liver parenchymal cell preparation appeared to be suitable for the study of the 
activity of some of the enzymes representative for the hepatic biotransformation 
of drugs. Further, modifications of this biotransformation due to certain changes in 
the cellular integrity and to drugs presumably acting on the permeability of the 
membranes could be analysed. It might be concluded that a suspension of isolated 
hepatic cells as described in this paper can be considered as a suitable tool for the 
analysis of various aspects of drug metabolism at the cellular level. 
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PHENOBARBITAL INDUCTION OF UDP-GLUCURONYLTRANSFERASE IN ISOLATED 
RAT HEPATGCYTES* 
P.Th. Handerson 
Institute of Pharmacology, Faculty of medicine, Uniuersity of Nijmegen, 
Nijmegen, The Netherlands 
SUmiïlARY 
UDPglucuronyltransferase actiuity u/ith p-nitrophenol as acceptor mas 
measured in parenchymal cells isolated from adult rat liver. There mas a 
gradual decline in the glucuronidating actiuity of the cells during a 
short-term culture in_ vitro. Addition of phénobarbital to the nutrient 
medium strongly delayed the decrease in UDPglucuronyltransferase actiu-
ity. The stimulatiue effect of phénobarbital appeared to be counter-
acted by a block of protein synthesis. These observations suggest that 
an enhanced synthesis of the conjugating enzyme can be induced in vitro 
in isolated hepatocytes. 
The administration in_ viuo of phénobarbital to mammals is ш іі-кпошп 
to give rise to a marked stimulation of the enzymatic activities involved 
in the hepatic oxidation of drugs and other foreign chemicals (1,2). The 
induced enzyme synthesis is related to a proliferation of the endoplasmic 
reticulum of the liver parenchymal cell, the main site of drug metabolism. 
ΙΪΙΟΓΘ recently a similar stimulative effect of phénobarbital treatment has 
been demonstrated for UDPglucuronyltransferase (UDPglucuronate glucuronyl-
transferase, E.G. 2.4.1.17), luhich catalyzes the glucuronyl conjugation 
of various endogenous and exogenous substrates and is also associated 
luith the endoplasmic reticulum of the liver (3,4). 
Ulith respect to the mechanism of action by which the inducer stimul-
ates the drug-metabnlizing enzymes, it might be questioned mhether the 
stimulation is based on a direct interaction between the inducer and the 
regulatory apoaratus in the liver cell uihich controls the enzyme syn-
supported in part by grants from the Netherlands' Organization for the 
Advancement of Pure Research (Z.IL.O.) 
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2 UDP-GLUCURONYLTRANSFERASE Vol. 10 
tl-esir, 'Γ uiletriGr f-.e iTd'.cticn i^ msdj-tGa by cartaio ey Ьгзгсрч»-,і
С 
EUbstanc33, for іп^і^ггч Ьгг^.-гзр. 
This communlcotlTn describes sore рг5Іі""і' ν с·:; в r y ι· ti ι.· г« ·η the 
response of a shurt-term culture of isolated rat hepatocyLss - a ьу.-t'ín· 
of livar cells not subject to uariations imposed in іцо by nerv/e, blood 
and hormonal supply - to the administration of phénobarbital j^ n uitro. 
lïlETHODS 
Single parenchymal cells from liuers of male Шізіаг rats (I7 r - 200 g) 
mere obtained as described preuiously by Henderson et al. (í.). The isolat-
ed hepatocytes шаге maintained in suspension at 37 С in Spinner flasks 
ccntaining Eagle's nutrient medium uiith 25 per cent heat-inactiua ted 
bovine serum. The gas phase mas ri per cent carbon dioxide in air. The 
cell suspension mas kept in motion by magnetic stirring. In inductijn 
experiments phénobarbital sodium mas added to the nutrient medium u/ith 
the final concentration of 300 μο/πιΐ . 
For the determination of UDPglucuronyltransferase activity p-nitro-
phenol mas used as glucuronyl acceptor. Samples ш г taken from the sus­
pension culture and the cell number шаз measured in a Pi'rker-Türk hemo-
cytometer. The cells mere collected by centrifugation at 200 д rir r min, 
mashed once in ice-cold saline, rasusperded in 0.05 ID Tris-HCl buffer 
( pH 7.Л), and hcmcnenized by ultrdsrnic vibration (b,6). The recic'.ion 
mixtures contained in a final voluma nf Π. 1 ml: 1С emoles Тгіь--ІГ1 buffer 
(pH 7.4), 1.0 íirole lïlçCl,-, 0.9 цтоіез saccharo-l, 4-lactone and saturating 
amounts of p-nitrcphenol (0.42 μηαΙθΒ) ond uridine 5'-diphc sphi cjlucurun-
ate (1.8 amóles). The reaction шаь startod by the addition of the s^ni-
r 
cated cell homogenate, équivalent to appr'.ximately S χ 1U J ceil·-. The 
incubation шч5 at 37 С fer 20 min nnrl the reaction mas stopped t'y the 
addition of 0.? ml ethanol. The glucurrnide pnduction mas measured in­
directly by deteininmg the disap^ncir. nee rf p-ni trophenol. Frr this 
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purpose aliquots of ths dsprotsinizad medium ш г diluted uiith 0.1 N NaOH 
and assayed spectrophotometrically at 39 nm. 
RESULTS 
As is shown in figure la the hepatic cells remain capable of conjug­
ating p-nitrophenol with glucuronate ewen after 6 days of culture. It 
can be obserued, however, that UDPglucuronyltransferase actiuity gradual­
ly declines during the cultiuatinn in uitro. Only 20 per cent of the 
initial conjugating actiuity has been maintained at day 6. Uhen the cells 
are cultured in the presence of phénobarbital, the decrease of the enzym-
atic actiuity is strongly delayed. In that case the mean actiuity at day 
б is about 40 per cent of the initial ualue. 
ρ
« of o n d i n a ! act iv i ty 
loo 
0o of untreated c o n t r o l 
FIG. 1 
Effect of phénobarbital administration to isolated rat hepatocytes on 
the glucuronidating actiuity. (a) UDPglucuronyltransferase actiuities 
expressed as percentages of the actiuities measured directly after 
isolation of the cells, (b) UDPglucuronyltransferase actiuities of 
phenobarbital-treated cells related to the actiuities of the corres-
ponding untreated controls. 
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If tha UDPglucuronyltransferase actiuities of the cells treated uiith 
phénobarbital are expressed relatlue to those of the corresponding un-
treated controls (figure lb), graphs can be obtained which are re.ninis-
cent of the gradual increase of hepatic drug metabolism commonly observed 
after repeated administration of phénobarbital ¿η uiuo. The average level 
of UDPglucuronyltransf erase in cell cultures treated uiith phénobarbital 
for 3 days is about 200 per cent of that in the untreated cultures. 
μ moles p-mtrophenol 
perhr- IO6 cella 
0.Ô 
ОбН 
ОМ 
02 m 
Су Р
+
Су 
FIG. 2 
Influence of cycloheximide on the stimulative effect of phénobarbital. 
UDPglucuronyltransferase activity measured after a culture period of 
3 days is expressed as μπιοΐββ p-nitrophenol conjugated per 10 6 cells 
per hour. Each bar denotes the average (+ 2 S.E.IT1.) for 5 experiments. 
Treatments: C, none; P, phanobarbital ^300 μς/ιτιΐ); Су, cycloheximi­
de (50 μ9/πιΐ); P + Cy, phénobarbital (3D0 цд/ті ) plus cycloheximide 
(50 цд/ті). Ρ significantly different from C, Cy, and P+Cy at D<0.01 
(Student's t-test). 
The question arose whether this stimulative effect of phénobarbital 
has to be ascribed to an induction of an enhanced synthesis of the enzyme 
or to an alteration in the rate of enzyme degradation. It was tested, 
therefore, whether the effect of phénobarbital on UDPglucuronyltransfer-
ase activity can be counteracted by a blockade of the protein synthesis. 
Phénobarbital was added to two cultures of isolated hepatocytes. Two other 
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cell culturas ssrued as controls, fit the start of the expariment cyclr-
heximida, an inhibitor of the synthesis of protein in animal cells (7), 
in a concentration of ' 0 i^g/ml nutrient medium mas added to .'ne control 
and one phenobarbital-treated cell culture. The experimental results are 
summarized in figure 2. It can be observed that the stimulation by phéno-
barbital is blocked for the greater part by cycloheximide. 
DISCUSSION 
The induction of higher levels of UDPglucurnnyltransferase activity 
in isolated rat hepatncytes cultured in the presence of phénobarbital 
may indicate that the technique employed is suitable for the study on 
phénobarbital induction at the cellular level. 
On account of the present data no conclusive explanation can be given 
for the decrease of the glucuronidating activity during the first days 
after isolation. IDhen examined by light microscopy no damage to the morph-
ological integrity of the isolated cells can be observed (Γι). It seems 
unlikely therefore, that the decreasing enzymatic activity i-, due to a 
leak of the enzyne invulved from the cells; tha more so as it has been 
generally accepted that the glucuronidating enzyme systems are insolubla 
and associated uiith the endoplasmic reticulum (6,θ). 
It is a comm in experience among (.ell cultivators that highly special­
ized cells - such as liver parenchymal cells - incline to dedifferent­
iate on cultivation in vitro. In this respect, our investigations on the 
chemical and physical conditions required to maintain the isolated liver 
cells optimally active in drug metabolism are continuing. 
Simultarenus 'raatment of tha isolated hepatocytes uiith eye 1 ohe/imida 
blocked the afect of phénobarbital. This is a strong argument in favour 
of the involvement t.f an enhanced da nr vo synthesis of the qlucun m.dating 
enzyme system in the induction of hiqhar І іч of UD^glucur ny] t. <)n«for­
ase by phennbarbital. 
β 
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Th· euscaptibility of single liuar cells Isolated from the orgenism 
to the stimulative effect of phénobarbital suggests that the induction 
of an enhanced glucuronideting activity in the liver ie not mediated 
through extrahapatic eubstancea such as hornones, but is due to a direct 
interaction botureen inducer and liver cell. 
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Abstract—Enzymatic activities for thep-hydroxylalion of aniline, the jV-demethylation 
of aminopyrine, and the UDPglucuronyl conjugation of p-nitrophenol of regenerating 
rat liver have been measured in vitro at different intervals following partial hepatectomy. 
The p-hydroxylating and /V-demethylating activities decreased during the period of 
rapid cellular proliferation and subsequently rose to about 100 and 80 per cent respec-
tively of their initial values within 7 days postoperatively. The UDPglucuronyltrans-
ferase activity, measured in ultrasonicated homogenates, however was not reduced 
during the regeneration process. Pretreatment of the rats with phénobarbital resulted 
in a considerable increase of the drug-oxidizing enzymes even during the period of rapid 
growth. The possibility that the changes of drug-oxidizing capacities of regenerating 
liver are related to the rate of liver growth is considered. 
MAMMALIAN liver, which ordinarily undergoes very poor proliferation, compensates 
for the loss of cells after partial removal by a rapid growth.1·2 In the course of this re-
generation the structure and chemical composition of the endoplasmic reticulum 
become modified in a characteristic way,3·4 accompanied by numerous biochemical 
events.5-7 
Von der Decken et al.3 and Fouts et α/.8 have reported decreased activities of some 
oxidative and reductive enzymes involved in the microsomal biotransformation of 
drugs after partial hepatectomy. It is noteworthy that liver tumors, fetal livers and 
livers of newborn mammals, all of which show a relatively rapid proliferation, have 
only a rather small capacity for metabolizing drugs.9 - 1 1 
The present paper describes enzymatic activities of the 7V-demethylation of amino­
pyrine and the p-hydroxylation of aniline measured at different intervals during 
regeneration following partial hepatectomy. The aim of this study was 'to establish 
whether there is any relationship between the change in activity of these drug-oxidizing 
enzymes and the rate of liver growth presented by the increase of liver weight, mitotic 
index, and the amount of DNA. The influence of liver regeneration on the respon­
siveness of the drug-oxidizing enzymes to pretreatment with phénobarbital was 
studied during the period of rapid cellular proliferation. Further it was examined 
whether the decrease in activity, as is observed for the microsomal oxidations, holds 
too for the in vitro activity of the conjugating enzyme p-nitrophenol glucuronyl-
transferase (UDPglucuronate glucuronyltransferase, EC 2.4.1.17). 
EXPERIMENTAL PROCEDURE 
Animals 
The animals used were adult male Wistar rats about 3 months old, weighing 150-
2343 
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180 g. Partial hepatectomy was carried out under ether anaesthesia according to the 
technique of Higgins and Anderson12 and about 70 per cent (median plus left lateral 
lobes) of the total liver was removed. In the sham-operated animals only the peritoneum 
was opened, and the wound closed as in the hepatectomized rats. 
In induction experiments laparotomized and hepatectomized animals received two 
injections of phénobarbital sodium (75 mg/kg, i.p.), 3 hr before and 12 hr after the 
operation. Control animals were injected with 0-5 ml 0-9% NaCl. 
Tissue preparations 
The animals were decapitated under light ether anaesthesia and the livers were 
rapidly excised. Portions of liver were weighed, minced and transferred into 4 vol. of 
ice-cold 0-25 M isotonic sucrose solution containing ΙΟ - 3 M sodium ethylenediamine 
tetraacetate (EDTA-Na) and 5 x IO - 2 M tris(hydroxymethyl)ammomethane-HCl 
buffer (pH 7-4). Homogenates were prepared using a Teflon-glass homogenizer in an 
ice-bath. Crude microsomal fractions were prepared from the homogenates by centri-
fugation at 9000 g for 20 min at 2°. The supernatant was used in the enzymatic assays 
for aminopyrine N-demethylation and aniline p-hydroxylation. The enzyme extracts 
employed in the in vitro estimation of the glucuronidation of/7-nitrophenol were liver 
homogenates treated in an ultrasonic disintegrator (MSE-100 Watt) for 1 min.13 
Enzyme assays 
The N-demethylation of aminopyrine was measured as previously described by 
Dewaide and Henderson.14 The assay mixture containing 5 A IO - 2 M Tris-HCl 
(pH 8-0), 5 χ I O 3 M semicarbazide, 8 > 10-ч M MgC^, 8 x I O 6 M МпСІг, 
5 χ Ю - 3 M sodium isocitrate (Sigma), 10 μg isocitric dehydrogenase/ml (Sigma type 
4, capable of reducing 5-7 > I0-3m-moles NADP/min/mg), 8-8 x IO-·5 M NADP and a 
saturating level of aminopyrine (16 7 χ 10 3 M), was preincubated for 10 min at 37' 
to ensure reduction of all NADP. The reaction was started by the addition of 9000 g 
supernatant fraction equivalent to 80 mg fresh liver. The total volume of the reaction 
mixture was 3 ml. After 10 min incubation at 37' the reaction was stopped by the 
addition of 0-5 ml 25% Z n S O W ^ O and 0-5 ml of a saturated Ba(OH)2 solution. 
After centrifugation the amount of formaldehyde was determined in the deproleinized 
supernatant following the method of Nash15 as modified by Cochin and Axelrod.16 
The incubation mixture for the assay of the /vhydroxylation of aniline had almost 
the same composition as the medium mentioned above, except for the substrate and 
coenzyme concentration which were for aniline 24 > ΙΟ' 3 M and for NADP 13 · IO - 5 
M. Semicarbazide was omitted. After incubation at 37c for 20 mm the reaction was 
stopped by the addition of 2 ml ethylacetate. /?-AminophenoI was extracted with ethyl-
acetate and determined following the phenol indophenol method.17 
For the measurement of the activity of UDPglucuronyltransferase /7-nitrophenoI 
was used as substrate. The ultrasonicated homogenates were incubated at 37' for 15 
min in a mixture consisting of Tris-HCI buffer (pH 7-4) (5 / IO - 2 M), MgCb (3-3 • 
Ю
- 3
 M), uridine-5-diphosphoglucuronate disodium salt (3 · 10'3 M). p-nitrophenol 
(1-4 χ Ю - 3 M) and saccharo-l,4-lactone (ΙΟ - 3 M). The total volume was 1-5 ml. The 
reaction was stopped by addition of I ml ethanol and the mixture centrifuged for 
15 min at 5000 g. The amount of conjugated product was measured indirectly by 
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determining the disappearance of p-nitrophenol. Aliquots of the deproteinized super­
natant were diluted with 01 N NaOH and assayed spectrophotometrically at 398 τημ. 
For all enzyme assays standard solutions and blanks were carried through the 
whole procedure and were used to quantify the enzymatic activities. 
DNA and protein assay 
DNA was determined by the diphenylamine test according to Burton18 after a pre-
extraction following Wanka.19 Calf thymus DNA (British Drug Houses) was employed 
as a reference standard. 
Protein contents of liver homogenates were determined following the method of 
Lowry et al.20 Bovine serum albumin (Sigma) was used as a reference standard in the 
calculation of the amounts of protein. 
Histological preparations 
Liver tissue (about 0-5 g) was fixed for 48 hr by 3-5% formaldehyde (neutralized by 
excess of СаСОз) in 10% CaCb. After fixation the tissue was embedded in paraffin 
and histological sections, 5-10 μ thick, were made, and stained with hematoxylin and 
eosin. The occurence of mitotic parenchymal cells was determined microscopically 
under oil immersion (x 1250). The mitotic indices were expressed as percentages of 
all nuclei of parenchymal cells. 
RESULTS 
Liver regeneration 
Simultaneously with ¿he activities of the drug-metabolizing enzymes the liver growth 
was followed at the different stages during the regeneration process. As can be seen 
from Fig. la the compensatory growth (weight increase) of the liver remnant is almost 
completed within 7 days. After a short latency period there is a rapid increase of the 
liver weight during the second and third day following the partial hepatectomy, which 
is mainly associated with a cellular hyperplasia. 
Most important events in this stage of rapid cellular growth are DNA synthesis and 
mitosis. The increase of total DNA content, expressed in Fig. lb per g liver dry weight, 
precedes the cellular division shown in Fig. 1c. Cell mitosis first appeared after 20 hr. 
Then the mitotic index rapidly rose to 4-5 per cent at 28 hr. This was followed by a 
gradual decrease and a second smaller mitotic wave between 40 and 60 hr. One week 
after the operation only few parenchymal cells in division were observed. These 
observations concerning the course of liver regeneration are in accordance with the 
more detailed analysis recently reported by Fabrikant.2 
p-Hydroxylation of aniline and N-demethylation of aminopyrine 
The in vitro activities of the p-hydroxylation of aniline and the 7V-demethylation of 
aminopyrine have been measured in 9000 g supernatants at different intervals after 
partial hepatectomy. In Fig. 2 it is shown that the rates of conversion of aniline and 
aminopyrine levelled down between 20 and 60 hr postoperatively to a minimum 
corresponding with the period of rapid growth of the liver, which has been indicated 
in Fig. 1. Thereupon an increase of the enzymatic activities could be observed con-
curring with the decline of the cellular proliferation. For the p-hydroxylation of aniline 
an about 100 per cent recovery of the activity was reached within 1 week after the 
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partial hepatectomy. However, the N-demethylation of aminopyrine was only about 
80 per cent of the initial value after 1 week. 
In order to avoid an interference by the increase of water content of the liver remnant, 
which was found to occur mainly during the first hours after partial hepatectomy, the 
enzymatic activities are presented here on the basis of liver dry weight. 
No remarkable changes in the amount of total liver protein per gram dry tissue 
were observed at the different intervals of regeneration. 
20 40 60 80 100 120 140 160 
Hours after parlial hepatectomy 
FIG. I. (a) Growth of the remnant liver after partial hepatectomy. Rat liver weight is expressed per 
100 g body weight. The normal value is presented by the dotted line. 
(b) The amount of liver DNA at different intervals expressed as milligrams per gram liver dry weight. 
(c) Temporal pattern of mitoses during rat liver regeneration. The mitotic index is expressed as per­
centage of all nuclei of parenchymal cells. Each point indicates the mean value ( 2 SE.) for six rats. 
Sham operation did not significantly affect the rate of /V-demethylation of amino­
pyrine (Table 1), nor the mitotic activity in the livers of the control animals. The 
question arose whether the low activities mentioned above are due to the presence of 
an inhibitor acting on the level of the enzymatic conversion or to a decrease in the 
enzyme concentrations during the liver regeneration. The results of enzyme assays in 
Metabolism of drugs during rat liver regeneration 2347 
10 
0 8 
0 6 
0 4 
>. 02 
> 
о 
о 
α* 
> 
о I 0 
CE 
08 
06 
0 4 
о г 
го 40 во во ιοο іго ио іео ιβο 
Hours after partial hepatectomy 
Pia. 2а, b. Hepatic p-hydroxylating and jV-demethylating activities, measured in 9000 g supematants, 
at different intervals during rat liver regeneration after partial hepatectomy. The mean enzymatic 
activities on the basis of liver dry weight are given here relative to their own initial values determined 
in the removed liver lobes. Each point indicates the mean ( ± 2 S.E.) for six animals. 
TABLE 1. JV-DEMETHYLATION OF AMINOPYRINE AFTER SHAM OPERATION 
Time of killing Percentage of the 
after laparotomy iV-demethylating activity* mean initial value 
5 min 14· 1-14-4 (14-3)t 100 
22 hr 12-5-130 (12-8) 90 
30 hr 14-3-14-5 (14-4) 101 
50 hr 13-4-13-8 (13-6) 95 
170 hr 13-6-13-2 (13-4) 94 
* Expressed as ^ moles formaldehyde produced per hour per gram liver. 
t The mean activity is given in parentheses. 
which mixtures of 9000 g supernatants from regenerating and from normal rat livers 
were incubated (Table 2) indicate that no inhibitor is involved in the lower rate of drug 
oxidation, since the combined enzyme preparations show N-demethylating and p-
hydroxylating activities nearly equal to the sum of the individual activities. 
In the induction experiments laparotomized and partially hepatectomized rats were 
injected twice with phénobarbital. The animals were sacrificed during the period of 
rapid regeneration, at 40 hr postoperatively, and the in vitro activities of hepatic N-
demethylation and p-hydroxylation were measured in 9000 g supernatants. The 
enzymatic activities appeared to be enhanced in both laparotomized and partially 
hepatectomized animals (Fig. 3). However, the response to phénobarbital is more pro-
nounced in the regenerating than in the sham-operated rats. 
Aniline 
— p-hydroxylotran 
1 I I I I I I I L 
Aminopyrine 
N-demethylation 
J L 
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TABLE 2. JV-DEMETHYLATING AND /?-HYDROXYLATING ACTIVITIES OF COMBINED 9000 g 
SUPERNATANTS FROM REGENERATING* AND NORMAL RAT LIVERS* 
Exp. 
number 
0-2 ml 9000^ 
supernatant from 
normal liver 
(A) 
Formaldehyde productiont per: 
0-2 ml 9000 g 
supernatant from 
regenerating liver 
(B) 
0-4· ml mixture of (C) 
0 2 ml A + 0-2 ml В 
(С) (A) + (B) 
160 
160 
160 
46 
77 
69 
219 
251 
231 
p-Aminophenol production^ per: 
0 1 ml 9000^ ' 0 1 mf9000£ 
supernatant from 
normal liver 
(A) 
supernatant from 
regenerating liver 
(B) 
0-2 ml mixture of 
0 1 ml A + 0 1 ml В 
ÍC) 
* The animals were killed 40 hr after partial hepatectomy. 
t Expressed in mamóles, measured after 10 mm incubation. 
Í Expressed in mamóles, measured after 20 min incubation. 
I 06 
106 
I 01 
(C) 
(A)+(B) 
4 
5 
6 
19-5 
19-5 
19-5 
81 
8-9 
104 
26-4 
27-9 
2 9 0 
0-96 
0-98 
0-97 
Control Regenerating Control Regenerating 
FIG. 3. Effect of pretreatment with phénobarbital on the /V-demethylation of aminopyrine and the 
p-hydroxylation of aniline by 9000 £ liver supernatants from laparotomized (control) and partially 
hepatectomized (regenerating) rats. Mean activities of jV-demethylation and p-hydroxylation are 
expressed here as micromoles formaldehyde and p-aminophenol respectively, produced per gram 
liver per hour. The broken lines indicate non-induced enzyme levels of unoperated rats. Ù treated 
with saline; Щ treated with phénobarbital 
0 6 
ρ- nitrophenol 
qlucuromdation 
20 40 60 80 100 120 140 160 200 
Hours after partial hepatectomy 
FIG. 4. Pattern of UDPglucuronyltransferase activity of ultrasonicated homogenates during rat liver 
regeneration after partial hepatectomy. The mean rates of conversion calculated on the basis of liver 
dry weight are expressed relative to the initial values measured in the removed liver lobes. Each point 
indicates the mean (-<_ 2 S.E.) for six rats. 
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U DPglucuronyltransferase 
Figure 4 shows the in vitro activity of UDPglucuronyltransferase determined at 
diflerent intervals during rat liver regeneration. Unexpectedly no decrease but even a 
little enhancement of the conjugating activity is manifested during the period of rapid 
proliferation. 
In order to exclude the possibility that the conjugating capacity is limited by per-
meability barriers between substrate or cosubstrate and the microsomal UDPglucuro-
nyltransferase, these in vitro studies have been carried out with liver homogenates 
which were further disintegrated by ultrasonication.13 The influence of change in mem-
brane permeability on the glucuronidating capacity has been reported previously.21 
DISCUSSION 
From the present results it becomes evident that there is a considerable loss in p-
hydroxylating and 7V-demethylating activity of the liver from 20 to 60 hr after partial 
hepatectomy. This decrease, however, cannot be directly related to the rate of division 
of the parenchymal cells, since already at 16 hr postoperatively the activities of these 
oxidative drug enzymes were significantly reduced, while cells in mitosis first appeared 
at20hr. Increase of the nuclear DNA content has been observed also at 16hr(Fig. lb), 
which is in agreement with the findings of Fabrikant,2 who reported that DNA synthe-
sis starts at about 12 hr after pai tial hepatectomy. Most likely all metabolic alterations 
during the early stages of liver regeneration are consequences of a common factor, which 
triggers dormant differentiated cells to entering an active phase of generative cycle. It 
has been supposed by Swann22 that while preparing for mitosis cells have to synthe-
size a number of specialized proteins, e.g. contractile proteins of the mitotic spindle. 
Since the total amount of protein per gram liver has not remarkably changed during 
the regeneration, it might be reasonable to assume that the protein-synthesizing 
apparatus for the most part is serving the cellular proliferation at that stage. This 
implies that the synthesis of proteins involved in more organ-specific functions like 
oxidative drug metabolism is falling off during this period of rapid proliferation, 
resulting in lower concentrations of these drug-oxidizing enzymes. This idea is sup-
ported by the finding that the lower enzymatic rates have to be ascribed to reduced 
concentrations of the catalytic proteins rather than to the presence of an inhibiting 
agent (Table 2). In addition, enzyme levels are also dependent on the rate of enzyme 
degradation. It cannot be excluded here that the observed lower /j-hydroxylating and 
jV-demethylating activities are caused by an increase of proteolytic enzyme activity. 
In this connection the numerous autophagic vacuoles, which have been reported23·24 to 
appear in the cytoplasm of the parenchymal liver cells during the early stages of liver 
regeneration, may play a part. 
From the induction experiments (Fig. 3) it can be concluded that drug metaboliz-
ing activities can be enhanced by phénobarbital pretreatment even during a period of 
rapid liver growth. Recently the responsiveness of regenerating rat liver to inducers of 
drug metabolism has been studied, too, by Gram et al.25 They reported an increase of 
drug metabolizing activities in regenerating livers from phénobarbital treated rats at 
day 6 after partial hepatectomy. It remains to be seen, however, whether that time is 
representative for the period of rapid regeneration, since—as appears from our results 
(Fig. 1)—the regeneration process has almost been completed within 6 days. 
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In contrast to the above decrease of enzymatic activities involved in oxidative drug 
metabolism during the period of rapid growth, which decrease has been demonstrated 
previously3·8 for other drug-oxidizing enzymes, the conjugating enzyme UDP-
glucurontransferase measured with p-nitrophenol is not lowered but even a little en­
hanced during the liver regeneration. This is surprising, since it has been reported that 
in other types of developing mammalian liver such as fetal and newborn liver'-6·'-7 
UDPglucuronyltransferase activity is much lower than in the adult preparations. In 
some preliminary investigations, however, we found that in ultrasonicated homo-
genates from fetal rat liver/?-nitrophenol UDPglucuronyltransferase activity is equal 
to that measured in ultrasonicated liver homogenates from adults. This affirms the 
supposition of Dutton,2 6 that it will not be possible to prove that deficient glucuromde 
synthesis in fetal liver is principally due to deficiency of the catalytic protein UDP­
glucuronyltransferase, until developmental studies are done with the solubilized 
enzyme. Since the relatively low rates of glucuronide synthesis in developing livers, 
as reported previously, are assayed either in vivo or in liver slices or in native liver 
homogenates, it seems acceptable that the relatively low values are attributable to a 
reduction of accessibility to the UDPglucuronyltransferase of the substrates. The 
enhanced activity m later stages may be caused by a change in the intracellular en­
vironment of the enzyme during the developmental process. 
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Abstract—Hepatic activities for the JV-demethylation of aminopynne and UDP-
glucuronyl conjugation have been determined in vitro during the perinatal period. 
UDPglucuronyltransferase activities measured with p-nitrophenol and bilirubin as 
acceptors in ultrasonicated homogenates are relatively high shortly after birth and 
subsequently decline to the adult level at day 10 post partum. The /V-demethylating 
activity remains low during the first 20 days after birth. In the 20 to 30-day period the 
enzyme activity of either sex suddenly rises. The hepatic activities in female rats reach 
their adult level during this period. As far as the males are concerned, the increase of 
their W-demethylating activity proceeds more gradually from the 30th day to a maxi-
mum at about 60 days, resulting in a marked sex difference in JV-demethylation. A change 
in the time of weaning did not influence drug metabolism in the developing rats. It is 
suggested that the lower level of oxidative JV-demethylation in the new-born rat is 
related to the presence of hemopoietic cells and to the rate of growth of the liver, rather 
than to a postnatal interference by maternal substances during the nursing period. 
NEW-BORNS of both animal and man commonly appear more sensitive to drugs than 
adults.1·2 The longer duration of action and the greater toxicity of drugs in the fetus 
and the newborn are mainly attributed to an apparent absence or low activity of the 
drug metabolizing enzymes in the liver.3·* 
About the cause of this lack of enzyme activity divergent opinions have been 
reported. Fouts and Hart4 considered that the low enzyme concentrations might be 
due to a lack of stimulus to the enzyme-forming systems. However, it was demon-
strated earlier that liver homogenates of newborn rabbits contain some material which 
inhibits the metabolism of amphetamine, hexobarbital, aminopyrine and acetanilid.5 
More recently Feuer and Liscio6·7 suggested that the depression of the hydroxylation 
of 4-methylcoumarin in the liver of fetal and newborn rats is caused through an inter-
ference by maternal inhibitory substances. 
Glucuronide synthesis, too, seems deficient in mammalian fetuses and new-
borns.3·8·9 Remarkably, Dutton10 found high levels of UDPglucuronyltransferase in 
rat liver homogenates just after birth of the animals. The contradictory reports 
induced us to re-study hepatic UDPglucuronyltransferase activities in vitro in the 
developing rat. In the present study the conjugation rates, using p-nitrophenol and 
bilirubin as acceptors, were measured with sonicated liver homogenates, to exclude 
any interference by differences in transport at the microsomal membranes.1 ^ 1 2 
Furthermore, the oxidative N-demethylation of aminopyrine was followed in crude 
microsomal fractions from the liver of the rat during the postnatal development. 
• Supported in part by grants from the Netherlands' Organization for the Advancement of Pure 
Research (Z.W.O.). 
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Efforts were made to correlate the observed alterations of the metabolic activities 
with the developmental status, represented by the rate of liver growth, the histologic 
changes in the liver, and the sexual differentiation of the animals. 
EXPERIMENTAL PROCEDURE 
Animals 
The animals employed in this study were Wistar rats, kept in an environment of 
constant temperature and humidity. The animals received water and a constant pellet 
diet ad lib. 
The fetal age was estimated from the time of mating. 
Liver preparations 
The animals were decapitated under light ether anaesthesia and exsanguinated. The 
livers were rapidly removed, weighed and finely minced. Homogenates (20%) were 
prepared in 0-25 M sucrose, containing 5 χ 10~2 M tris(hydroxymethyl)amino-
methane-HCl (pH 7-4) and ΙΟ - 3 M sodium ethylenediamine tetraacetate (EDTA-Na) 
using a Teflon-glass Potter-Efvehjem type of homogenizer. In the preparation of 
homogenates from fetal rats three to nine livers were pooled to obtain sufficient 
amounts for analysis. 
Crude microsomal fractions were prepared from the homogenates by centrifugation 
at 9000 g for 20 min. The supernatant was employed in the enzyme assay of the 
N-demethylation of aminopyrine. The enzyme preparations used in the in vitro 
estimation of the glucuronyl conjugation were liver homogenates further disintegrated 
by ultrasonic vibrations.12 
Enzyme assays 
UDPglucuronyltransferase activity with p-nitrophenol as acceptor was determined 
as described previously.12 The reaction mixture consisted of tris-HCl buffer (pH 7-4) 
(5 x IO"2 M), MgCl2 (3-3 χ IO"3 M), saccharo-l,4-lactone (3 χ ΙΟ"3 M) and 
saturating levels of ^ -nitrophenol (1-4 χ 10~3 M) and uridine-5'-diphosphoglucuron-
ate (6 x 10" 3 M). The reaction was started by adding the sonicated homogenate, 
equivalent to 60 mg of fresh tissue, to a final volume of 1 -5 ml. The incubation was at 
37° for 20 min and the reaction was stopped with a 1 ml ethanol, followed by centri­
fugation. The glucuronide production was measured indirectly by determining the 
disappearance of free /»-nitrophenol. Aliquots of the deproteinized supernatant were 
diluted with 01 N NaOH and assayed spectrophotometrically at 398 nm. 
The rates of glucuronyl conjugation with bilirubin as acceptor were determined 
according to the method of Lathe and Walker* with slight modifications. The incu­
bation mixture had the same composition as the medium used in the assay of p-nitro-
phenol glucurûnidation, except for the acceptor and its concentration. Bilirubin was 
added to a concentration of 5 χ 10"* M. The incubation was at 37° for 30 min. The 
conjugated bilirubin was estimated by the direct diazo reaction. 
The ЛГ-demethylation of aminopyrine was measured as described previously.11,13 
The assay mixture, containing tris-HCl (pH 80) (5 χ 10"2 M), semicarbazide 
(5 χ IO"3 M), MgCl2 (8 χ IO"4 M), MnCl2 (8 χ IO"6 M), sodium isocitrate 
(S x 10" 3 M), 10 /ig isocitric dehydrogenase/ml (Sigma type 4, capable of reducing 
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5-7 x Ю - 3 mmoles NADP/min/mg), NADP (8-8 χ 10"* M), and a saturating level 
of aminopyrine (16-7 χ 10"3 M), was preincubated for IO min at 37° to ensure 
reduction of all NADP. The reaction was started by the addition of the 9000 g super­
natant fraction, equivalent to 80 mg fresh tissue. The total volume of the reaction 
mixture was 3 ml. After 10 min incubation at 37° the reaction was stopped by adding 
0-5 ml 25% ZnSO« and 0-5 ml of a saturated Ba(OH)2 solution. The precipiuted 
protein was removed by centrifugation and the amount of formaldehyde was deter­
mined in the supernatant according to the method of Nash14 as modified by Cochin 
and Axelrod.15 
Standard solutions containing all reagents and heat-denatured homogenate were 
carried through the whole procedure, and served as blanks. 
Protein assay 
Protein content of the livers was determined following the method of Lowry et al. ' * 
Bovine serum albumin (Sigma) was used as a reference standard. 
Histological preparations 
Liver tissue, about 300 mg, was fixed for 2 hr in Camoy's solution. After fixation the 
tissue was embedded in paraffin. Histological sections, S μτη thick, were made, and 
stained with hematoxylin and eosin. 
R E S U L T S 
Liver growth 
In Fig. la the liver weights are plotted logarithmically as a function of the age of the 
rat. Two main phases can be distinguished in the postnatal liver growth. From birth 
until about 30 days post partum considerable increase in liver wet weight occurs with a 
doubling time of about 7 days. This stage of relatively rapid growth is followed by a 
period of much slower growth. During the latter period the time of doubling amounts 
to nearly 140 days. 
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Flo. 1. (·) Liver weight of the postnatal rat. The liver wet weights are plotted logarithmically as a 
Amction of age. Bach circle represents the mean (±S.E.M.) of three to twelve samples. Male rats 
were employed, (b) Change of the amount of liver dry weight in relation to liver wet weight and 
change of protein concentration (broken line) during the postnatal development of the rat liver. The 
protein concentrations are expressed as the amounts of protein per gram fresh liver. Each circle with 
bar represents the mean (±S.E.M.) of three to six animals. Rats of either sex were employed. 
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For the first period of growth, the neonatal growth, an increase of the liver dry 
weight has been observed, which is accompanied by a rise in liver protein concentra­
tion (Fig. lb). Thereupon the composition of the liver remains constant as far as dry 
weight and amount of protein are concerned. 
The rate of liver growth presented in Fig. la has been measured with male rats. It has 
to be remarked, however, that no sex difference for liver weight has become apparent 
until after 40 days of age. Weights of livers from adult female rats (60 days old) were 
found to be 70-75 per cent of those from adult males 
In the determinations of dry weight and protein concentrations rats of either sex 
were employed and no differences between male and female animals became apparent. 
Glucuronyl conjugation 
Hepatic UDPglucuronyltransferase activities were measured, with p-mtrophenol as 
acceptor, in whole homogenates, which were treated with ultrasound prior to incu­
bation. The ultrasonic treatment of the liver preparation results in a considerable 
activation of the glucuromdating activity, as has been described previously.12 The 
conjugating capacity during rat liver development is presented in Fig. 2. The glu-
curonyltransferase activities of 14 and 16 days old fetal livers calculated on the basis of 
liver dry weight are about 25 per cent of the adult level. Remarkably high activities 
(until about 300 per cent of the adult level) are found during the first week after birth. 
Sex of the animals was not identified until after 1 day of age With respect to /?-nitro-
phenol glucuronyltransferase activities no sex differences have been observed during 
the neonatal period. For adults, however, in this respect relatively small differences 
have been found (Fig. 2) at day 60 01 > Ρ > 005; at day 90 P < 001, Wilcoxon two-
sided, two-sample test. The average rates of p-nitrophenol conjugation with sonicated 
liver homogenates from adult females were 80 per cent of those from male rats. 
A relatively high UDPglucuronyltransferase activity, too, has been found in liver 
homogenates from new-borns using bilirubin as acceptor. These enzyme activities, 
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expressed as ^moles bilirubin glucuronidj produced per gram dry tissue per hr, were 
41-5 ± 3-9 and 17-2 ± 1·7 for male rats at day 4 and day 60 respectively. 
N-demethylation of aminopyrine 
The developmental pattern of the oxidative AMemethylation of aminopyrine is 
shown in Fig. 3. The enzymatic activities of male and female rats, measured with 
9000 g supernatants, are low during the neonatal period. An increase of the activities 
can be observed between the 20th and 30th day after birth. During this period the 
young female animals already reach their adult level. However, as far as the males are 
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Fra. 3. PoetMtal development of hepatic iV-demelhylation of aminopyrine in the rat. The enzymatic 
activities, measured with 9000 g supernatants, are given as emoles formaldehyde produced per hour 
per gram dry liver: О male; φ female. 
concerned, the relatively rapid rise of their N-demethylating capacity is followed by a 
more gradual increase to attain maximal levels of the enzyme system at about 2 months 
of age. It is noteworthy that, in contrast with the UDPglucuronyl conjugation, a sex 
difference in the rate of aminopyrine metabolism becomes manifest starting at about 
30 days post partum. 
It has been suggested by Feuer et al., that the lower rate of conversion in the liver of 
the newborn is caused by an interference of maternal inhibitors. The intake of these 
substances by the newborn should be suddenly reduced by weaning. Consequently it 
was to be expected that a postponement of the time of weaning would result in a delay 
of the increase of enzyme activity. Two groups of animals of the same age were tested. 
Rats of the control group were normally weaned at 21 days after birth. The group of 
non-weaned animals were kept with the mother and mainly fed with mother's milk. 
Body weight, liver wet weight, liver dry weight and enzymatic activities of the weanling 
and suckling rats were determined and compared 10 days later. We were not able to 
detect any significant influence of a prolonged nursing period on the JV-demethylation 
or UDPglucuronidation in developing rats (Table 1). 
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TABLE 1 METABOLISM OF DRUGS IN DEVELOPING RATS* AFTER NORMAL AND PROLONGED 
NURSING PERIODS 
Normally weaned at 
21 days after birth Non-weaned 
Body weight (g) 54 5 t 3 2 (8)t 56 5 + 4 8 (7) 
Liver wet weight (g) 3 07 t 0 25 (8) J 06 -fc 0 34 (7) 
Liver dry weight (g) 1 05 ± 0 09 (8) 0 99 ± 0 13 (7) 
ЛГ-demethylation of ammopynneî 29 3 i- 3 3 (18) 29 4 ± 3 9 (17) 
UDPglucuronidationof/>-nitrophenol§ 187 8 1-17 7 (8) 179 6 ± 1 6 7 (11) 
• Male 31-day-old rats were used in the assa>s 
f All values are means ± S D , numbers of animals are given in parentheses 
i Expressed as ¿¿moles formaldehyde produced per hour per gram dry tissue 
§ Expressed as jxmoles p-mtrophenol disappeared per hour per gram dry tissue 
Histological changes 
The liver is one of the main sites of blood formation during the development of the 
mammalian fetus 17 A great number of extravascular blood cells of varying types and 
stages of differentiation is located between the strands of parenchymal liver cells 
Toward the end of gestation the hemopoietic activity of the liver declines For the rat 
we observed that a considerable amount of foci of erythroblasts, however, remains in 
the liver during the first week after birth About 20 per cent of all ceUs in the liver were 
found to be developing blood cells at the 3rd postnatal day These cells are smaller 
than the hepatocytes, and can be easily recognized by their strong basophilia. Further 
it is noteworthy that at this time the hepatic cords are more widely separated by 
sinusoids than at later stages. The hemopoietic elements gradually disappear and are 
only sporadically found after 3 weeks post partum. 
DISCUSSION 
The observations of the increased and subsequently declining levels of p-mtrophenol 
UDPglucuronyltransferase shortly after birth of the rat (Fig 2) are consistent with the 
data of Dutton.10 In the present study, however, sonicated liver homogenates were 
applied. The ultrasonic treatment only increased the apparent enzyme activity but did 
not alter the developmental pattern as indicated by Dutton l 0 It can be concluded, 
therefore, that the varying rates of conjugation during the perinatal period of the rat 
must principally be ascribed to different levels of the catalytic proteins, rather than to 
differences in transport at the microsomal membranes 
During some preliminary studies the m vitro rates of bilirubin glucuronidation, too, 
appeared strongly increased at day 4 after birth. These observations raise the teleologie 
question, whether there is any relationship between the perinatal peak of glucuromdat-
ing activity and the neonatal jaundice caused by the extensive destruction of erythro-
cytes usually occurring immediately following birth Bakken et α/.18 have supposed 
that the accumulation of unconjugated bilirubin acts as a trigger for the conjugating 
system. Accordingly, the temporary equipment of the neonatal rat with a high 
conjugating capacity might be considered as an adaptive response to the rapid rise of 
the bilirubin content 
FIG. 2. Photomicrographs of liver sections iron 3 days (a) and 21 days old rats (b). 
Groups of developing blood cells (dark stained) are still abundantly present in the 
liver of the newborn rat. These cells gradually disappear and only occur occasionally 
3 weeks after birth. Hematoxylin and eoein. (x 330). 
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The pattern of the oxidative A'-demethylation in relation to age and sex greatly 
differs from that of the drug-conjugating enzyme U DPglucuronyltransferase. The 
finding of the relatively low in vitro activity of A'-demethylation in the ral liver shortly 
after birth is in accordance with that reported by Soyka"' and by Bri:snick and 
Stevenson.20 However, as is illustrated in Fig. 3, the present study reveals a sudden 
elevation of the enzyme activity for either SLX in the 20 to 30-day period after birth. As 
far as the young male animals are concerned, this increase then proceeds more gradually 
to a maximum level at about 60 days, with as a result a marked sex difference m 
W-demethylation. It has been reported by Kato et al.2122 that the activity of drug 
oxidation in the liver is enhanced by male sex hormones. Most likely, therefore, the 
sexual difTerentiation underlies the latter phase in the postnatal development of 
W-demethylation of the male rat. This idea is supported by the fact, that this period 
corresponds to the time of testicular descent in the rat, which has been reported to take 
place between the 30th and 40th day.23 As already mentioned, Feuer and Liscio6·7 
have suggested that the deficiency of drug oxidation in the liver of justborn rats is 
connected with an inhibition derived from the maternal environment. It was supposed 
that weaning of the animals results in an acceleration of the hepatic drug metabolism 
through a reduction of the maternal inhibitory effects. Our studies, however, have 
failed to reveal any influence on drug metabolism of the change of diet from mother's 
milk to solid food. No differences could be observed between weanling and pre-
weanling rats of the same age (Table I). 
Presumably, the origin of the low enzyme activity is more complex. Although the 
liver has lost its major function in hemopoiesis after birth, developing blood cells 
still form an important part of the hepatic tissue during the first days postnatally. 
Hence it is understandable, that the relatively lower quantity of parenchymal cells— 
the main sites of drug oxidation—results in a lower capacity of the neonatal liver for 
yV-demethylation. 
In addition, evidence has been presented previously by Henderson and Kersten,13 
that a decreased Ics el of drug oxidation during rat liver regeneration is associated with 
the rapid cellular proliferation of the liver. As appears from the present study the same 
holds true for the /V-demethylation during the neonatal development of the rat liver. 
The period of poor /V-demethylating activity from birth until 30 days post partum 
corresponds exactly with the period of rapid growth (Fig. 1 ). An increase of the enzy-
matic activity can be observed concurrent with the decline of the liver growth. 
It might be concluded, therefore, that the level of hepatic drug oxidation in the 
developing rat is idatcd- -at least in part - to the rate of liver growth. The recent 
findings of Wilson,24 which strongly indicate that a relatively high level of the growth 
hormone (STH) in blood has to be considered as one of the regulating conditions of 
hepatic drug oxidation, support this view. 
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S U M M A R Y 
In this thesis some investigations into the biotransformation 
of drugs with the aid of different preparations of liver are 
described. Apart from the intention to study some properties 
of drug-metabolizing enzymes in preparations from livers in 
uncommon conditions, these investigations were also undertaken 
so as to gather information about the possibility of establish-
ing a continuous culture of liver cells suitable for the study 
of drug metabolism. The results of these investigations can be 
summarized as follows: 
Optimal conditions for the in vitro assay of the hepatic 
N-demethylation of aminopyrine have been investigated with 
9000 g supernatants derived from liver homogenates. It appear-
ed that maximal N-demethylating activities of these liver pre-
parations from the rat can be measured at 37° only during a 
short incubation period (5-10 min). The optimal pH was found 
to be approximately 8 (1.1). 
It has been further demonstrated that treatment of rat liver 
homogenates with ultrasound results in a 3-4 fold increase in 
UDPglucuronyltransferase activity (1.2). It is supposed that 
this stimulation is due to a disintegration of possible barriers 
between substrate or cosubstrate and the active sites of the 
enzyme. Kinetic studies at varying acceptor and UDPglucuron-
ate concentrations have shown that ultrasonic treatment of the 
liver homogenate causes a significant increase in the apparent 
Km-values for UDPglucuronyltransferase. The mechanical treat-
ment as described may be considered as a rapid procedure for 
the solubilization of the enzyme. 
The enzymatic activities for the N-demethylation of amino-
pyrine, the p-hydroxylation of aniline, and the glucuronyl 
conjugation of p-nitrophenol have been measured in isolated 
rat hepatic cells (intact and disrupted), and compared to those 
in homogenates from fresh liver tissue on the basis of DNA con-
tent and to the activities of crude microsomal fractions pre-
pared from these homogenates (II.1). SKF 525 A, a known inhib-
itor of drug metabolism, blocked the glucuronidation only in 
the intact isolated cells and not in the homogenates. In con-
trast, N-demethylation was inhibited by SKF 525 A both in the 
intact cells and in the disrupted cells, and in 9000 g super-
natants from fresh liver homogenates. These observations 
indicate that for the N-demethylation a true enzyme inhibition 
may be involved, while for the glucuronidationa change in the 
properties of the membranes leading to a reduced permeability 
for substrate or cosubstrate is more pronounced. 
XII 
XIII 
The suspension of isolated hepatocytes appeared to be suit-
able for studying various aspects of drug metabolism, especially 
the modifications in metabolism resulting from changes in cell-
ular integrity and membrane permeability. 
During a short-term in vitro cultivation the glucuronidating 
capacity of the isolated cells gradually declined (II.2). Ad-
dition of phénobarbital to the nutrient medium strongly delayed 
the decrease in UDPglucuronyltransíerase activity. This stimul-
ative effect of phénobarbital could be counteracted utilizing 
a blocker of protein synthesis (cycloheximide). These observ-
ations demonstrate that an enhanced synthesis of the conjugat-
ing enzyme can be induced in vitro in the isolated hepatocytes, 
and may contribute to the understanding of the mechanism of 
the induction of drug metabolism. 
During a period of rapid cellular proliferation of the liver, 
following partial hepatectomy, the p-hydroxylating and N-de-
methylating activities decreased (III.l). The UDPglucuronyl-
transferase activity, measured in ultrasonicated homogenates, 
however, was not reduced during the regeneration process. The 
lower enzymatic rates of drug oxidation have to be ascribed to 
reduced concentrations of the catalytic proteins and not to the 
presence of an inhibitor. A correlation between a low level of 
drug oxidation and rapid proliferation of liver tissue was also 
observed in neonatal rat liver (III.2), where the N-demethylating 
activity remains low during the first 20 days after birth. This 
does not hold for the glucuronidating enzymes. UDPglucuronyl-
transferase activities, measured with p-nitrophenol and bili-
rubin as acceptors, were found to be relatively high shortly 
after birth of the rat. 
With regard to the study of drug metabolism in a continuous 
cell culture, it might be concluded from the results mentioned 
above, that proliferation of the liver cells leads to reduction 
of the enzymes involved in the oxidative reactions. This kind 
of dedifferentiation, however appeared to be reversible. In 
contrast with the oxidative enzymes, UDPglucuronyltransferase 
activity is preserved during the period of rapid liver growth. 
In some cases there are even indications for an enhanced gluc-
uronidating capacity. When these data are taken into consider-
ation, it can be expected that in a continuous liver culture, 
consisting of rapidly proliferating cells, the glucuronidating 
capacity is maintained. However, the enzyme systems involved 
in the microsomal oxidation of drugs seem to be at a higher 
level of complexity. It follows that the latter enzymes may 
only be present in the active form -comparable to the activ-
ities of hepatocytes in vivo- when the cells are in a resting, 
nonproliferative state. 
S A M E N V A T T I N G 
In dit proefschrift zijn de resultaten beschreven van een 
onderzoek naar de biochemische omzetting van farmaca in ge-
isoleerde levercellen en prolifererend leverweefsel. Uitgangs­
punt voor deze studie was het nagaan van de mogelijkheid om 
een continu groeiende kweek van levercellen te vestigen, die 
geschikt is voor onderzoek naar het metabolisme van farmaca. 
Tijdens dit onderzoek konden bepaalde eigenschappen van enige 
enzymen, welke een rol spelen bij de ontgiftingsprocessen in 
de lever, worden gekarakteriseerd aan de hand van de bestude­
ring van de enzymatische activiteiten van diverse leverprepa­
raten. De voornaamste resultaten kunnen als volgt worden samen­
gevat : 
Optimale omstandigheden werden bepaald voor de in vitro 
reactie van de N-demethylering van aminopyrine. In 9.000 g 
supernatants verkregen uit homogenaten van rattelever konden 
maximale N-demethyleringsactiviteiten bij 37° С alleen worden 
gemeten gedurende korte incubatietijden (5-10 min.). Het pH 
optimum voor deze reactie ligt ongeveer bij pH 8 (1.1). 
Behandeling van leverhomogenaten met ultrasonische vibra­
tie veroorzaakte een sterke stimulering van de UDPglucuronyl-
transferase activiteit (1.2). Waarschijnlijk is deze active­
ring een gevolg van een desintegratie van bepaalde barrières 
tussen het substraat of cosubstraat enerzijds en de actieve 
plaatsen van het enzym anderzijds. Uit kinetische experimenten 
bleek dat de ultrasonische behandeling een belangrijke toename 
van de schijnbare Km-waarden van p-nitrophenol en UDPglucuro-
naat tot gevolg heeft. De genoemde behandeling kan worden 
beschouwd als een snelle methodiek om UDPglucuronyltransferase 
meer oplosbaar te maken. 
De enzymactiviteiten van de N-demethylering van aminopyri-
ne, de p-hydroxylering van aniline en de glucuronidering van 
p-nitrophenol in geïsoleerde levercellen van de rat werden op 
basis van DNA-concentratie vergeleken met de betreffende ac-
tiviteiten in homogenaten en microsomale fracties bereid uit 
vers leverweefsel. De waarneming, dat SKF 525 A, een bekende 
remmer van het metabolisme van farmaca, de N-demethylering 
in alle leverpreparaten remt, terwijl de glucuronyl conjugatie 
alleen wordt geblokkeerd in de geïsoleerde intacte levercellen, 
suggereert twee verschillende werkingen van deze stof: een 
directe enzymremming en een aspecifiek effect berustend op een 
verminderde permeabiliteit van de cellulaire membranen. 
XIV 
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Het preparaat van de geïsoleerde levercellen bleek een 
geschikt proefobject te zijn om een aantal aspecten van de 
biotransformatie van farmaca te bestuderen op cellulair niveai. 
Wanneer de geïsoleerde levercellen gedurende enige tijd in 
suspensie werden gekweekt, trad geleidelijk een daling van de 
glucuronideringscapaciteit op (II.2). Toevoeging van fenobar-
bital, een bekende inductor van het metabolisme van farmaca 
in vivo, aan het voedingsmedium gedurende enkele dagen resul-
teerde in een relatieve toename van de glucuronideringsactivi-
teit per cel. Deze stimulerende werking van fenobarbital kon 
worden verhinderd door gelijktijdig de celcultuur te behandelen 
met cycloheximide, een remmer van de eiwitsynthese. Dit wijst 
erop, dat het mogelijk is m.b.v. fenobarbital de synthese van 
UDPglucuronyltransferase te stimuleren in een in vitro systeem 
van levercellen. Een resultaat dat wellicht kan bijdragen tot 
een beter inzicht in het mechanisme van de fenobarbital induc-
tie. 
Gedurende de periode van snelle groei tijdens het regene-
ratieproces, volgend op een partiële hepatectomie bij de rat, 
werd een verlaging waargenomen van de in vitro activiteiten 
van de p-hydroxylering en oxydatieve N-demethylering (III.1). 
De activiteit van het conjugerende enzym, UDPglucuronyltrans-
ferase, bleef nagenoeg onveranderd tijdens de periode van 
levergroei. De activiteitsverlaging van beide oxydatieve enzym-
systemen moet worden toegeschreven aan een verlaging van de 
enzymconcentraties en niet aan de aanwezigheid van remmende 
factoren. Het samengaan van een gering vermogen om farmaca te 
oxyderen en een snelle groei van de lever werd eveneens gecon-
stateerd bij pasgeboren ratten (III.2). Gedurende de eerste 
20 dagen na de geboorte bleek de N-demethyleringsactiviteit 
bijzonder laag te zijn. De UDPglucuronyltransferase activitei-
ten, gemeten met p-nitrophenol en bilirubine als acceptoren, 
vertoonden daarentegen een piek vlak na de geboorte. 
Blijkens bovengenoemde resultaten leidt proliferatie van 
de levercel dus in het algemeen tot een afname van het vermo-
gen om farmaca te oxyderen. Dit geldt niet voor de activiteit 
van UDPglucuronyltransferase. Wanneer men deze gegevens in 
aanmerking neemt, kan men verwachten dat ineen continu groei-
ende levercultuur - bestaande uit snel delende cellen - een 
capaciteit om te glucuronideren behouden blijft. De enzymsys-
temen die betrokken zijn bij de microsomale oxydaties, lijken 
daarentegen inherent aan een hogere graad van differentiatie 
en zullen dientengevolge wellicht alleen voorkomen in "rust-
ende", niet-prolifererende cellen. 
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